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1. Synthesis of Bruceantin Analogs 
Bruceantin (1.1, Figure 1) was isolated from Brucea antidysenterica, an Ethiopian tree 
traditionally used in cancer therapy, and its structure was first reported by Kupchan and 
coworkers in 1973.1 It belongs to the quassinoid natural product family of which more than one 
hundred and fifty members have been isolated and reported.2 Brusatol (1.2, Figure 1.1) is a 
closely related quassinoid differing only in the C-15 ester side chain.3  
 
Figure 1.1 Structures of Bruceantin and Brusatol 
Since reports of its isolation, bruceantin has been well studied for its antitumor activity.4 
Brusatol also shows cytotoxic effects against leukemia cell lines.5 The mode of action of these 
quassinoids is attributed to their ability to interfere at the peptidyl-transferase site and inhibit 
protein synthesis.6 Many structure-activity relationship studies have been conducted on the 
quassinoid family of natural products. It has been proposed that the A-ring acts as a Michael 
acceptor as saturation of the A-ring lessens cytotoxic activity.7 In the same ring, a free hydroxyl 
group at either C-1 or C-3 leads to an enhancement of biological activity, seemingly because of 
the ability to hydrogen bond to the enone in an intramolecular fashion and increase 
electrophilicity.7 Grieco and coworkers demonstrated the importance of the D ring lactone by 
synthesizing a quassinoid derivative lacking the D-ring, and found that it had no activity against 
solid tumors.8 Kupchan et al. reported that the C-15 ester is necessary for activity against P-388 


































more potent than the saturated analogs.9,10 The authors suggested that the ester group may be 
involved in cellular transport.9  
Bruceantin has progressed into three phase I and two phase II clinical trials.2 In 1983, 
fifteen patients with metastatic breast cancer received bruceantin treatment in a phase II clinical 
trial.11 Only two patients showed any response and all suffered from severe side effects, so the 
trial was terminated. The following year, bruceantin underwent the second phase II trial on 
twenty-two patients with malignant melanoma.12 Again, poor response and severe side effects led 
to termination of the trial.   
More recently, in a screen of 2220 small molecule drugs, the Robertson Laboratory in the 
Department of Microbiology at the University of Pennsylvania identified bruceantin and brusatol 
as inhibitors cancer cell lines associated with the γ-herpes viruses Epstein-Barr virus (EBV) and 
Kaposi’s sarcoma-associated herpes virus (KSHV).13 Both compounds inhibited all cell lines 
tested at 0.5 µM or less. EBV is associated with many B-cell lymphomas including Burkitt 
lymphoma, Hodgkin lymphoma, and diffuse large B-cell lymphoma.14 There is currently no 
treatment for EBV.15 KSHV is believed to cause Kaposi’s sarcoma, which commonly occurs in 
AIDS patients.16 Although highly active antiretroviral therapy can be effective against Kaposi’s 
sarcoma,16 novel treatments are needed.  In collaboration with the Robertson Laboratory, we 
sought to develop analogs of these quassinoid natural products for biological study in the 
treatment against these γ-herpes virus-associated lymphomas.  
1.1 Proposed Amide Analog of Bruceantin  
At the outset, we were interested in replacement of the C-15 ester side chain with the more 
stable amide analog (1.5, Figure 1.2).  This strategy has been applied in the development of 
BMS-247550 1.4 from epothilone B (1.3, Figure 1.2).17 This successful change from the ester to 
the amide suggested that the amide analog 1.5 would exhibit improved metabolic stability relative 




been studied,18 to the best of our knowledge, no compounds bearing amide chains at C-15 have 
been isolated or synthesized.   
 
Figure 1.2 (a) Structures of Epothilone B 1.3 and BMS-247550 1.4 (b) Structures of Brusatol 
1.2 and Proposed Amide Analog 1.5 
In a retrosynthetic sense, we envisioned key amide analog 1.5 would come from 
acylation of the C-15 primary amine 1.6 (Scheme 1.1). Equatorial amine 1.6 would be formed 
from epimerization of the axial amine 1.7, the kinetically favored reductive amination product of 
ammonia and the C-15 ketone, 1.9, via the intermediacy of imine 1.8. It was expected that 
reduction of 1.8 would come from the convex face of the ring system to generate the undesired 
C-15α stereochemistry of 1.7 that would then need to be epimerized to the desired C-15β 
stereochemistry of 1.6. Ketone 1.9 would come from selective oxidation of the C-15 hydroxyl of 
alcohol 1.10, derived from ester hydrolysis of 1.2.  




























































































































1.2  Attempts to Synthesize Amide Analog 1.5 via Oxidation to 1.9 
 The A-ring enol ether of 1.2 was selectively protected as the tert-butyl dimethylsilyl enol 
ether, and the C-15 ester side chain was hydrolyzed following the procedure of Tang and 
coworkers to generate key intermediate 1.11 (Scheme 1.2).19 With key intermediate 1.11 in hand, 
conditions to oxidize the C-15 hydroxyl selectively in the presence of the C-12 and C-11 
hydroxyls to ketone 1.9 were explored. Swern conditions gave a complex reaction mixture, and 
no desired product was isolated.  Ley oxidation conditions gave no reaction of starting material 
even after prolonged reaction time. TEMPO-mediated oxidation also gave no reaction of starting 
material.20 Chromium oxidants and Parihk-Doering conditions also returned unreacted starting 
material. The most promising conditions were found using Dess Martin periodinane. On the first 
attempt, although the reaction appeared to proceed relatively cleanly as monitored by thin layer 
chromatography, after aqueous workup many products were observed.  In a second attempt the 
crude reaction mixture was loaded directly onto silica gel for purification, but again, multiple new 
products were formed, none corresponding to the desired ketone.  This suggested that the C-15 
ketone 1.9 may be too unstable to be isolated and an alternate pathway was designed.   
 
Scheme 1.2 Attempted Oxidation of 1.11 to 1.9 
1.3  Attempts to Synthesize Amide Analog 1.9 via Displacement  
 Given the difficulty of synthesizing the desired ketone intermediate 1.9, a new 
retrosynthetic route was developed (Scheme 1.3).  We envisioned that the necessary primary 
amine 1.7 could come from reduction of azide intermediate 1.12. Azide 1.12 would be generated 






































1.13 would come from selective activation of the C-15 alcohol of 1.10. Alternatively, Mitsunobu 
reaction of 1.10 with a nitrogen source could be used.  Again, this route would require an 
epimerization of the C-15 stereochemistry (1.7 to 1.6) as displacement with the azide source and 
subsequent reduction would give C-15α.  
 
Scheme 1.3 Second Generation Retrosynthetic Analysis of Amide Analog 1.5 
Because a Mitsunobu reaction could deliver a nitrogen-containing compound in one step 
without the need to first activate the hydroxyl of 1.11, these conditions were explored first 
(Scheme 1.4).  Treatment of 1.11 with O-(tert-butyldimethylsilyl)-N-tosylhydroxylamine in the 
presence of triphenylphosphine and diethyl azodicarboxylate in a dilute (0.25 M) 
toluene/tetrahydrofuran solvent mixture led to no reaction, even upon extended heating.  Under 
very concentrated conditions (3 M, sonication), many new products were observed after a short 
reaction time.  Treatment of 1.11 with diphenylphosphoryl azide (DPPA) in the presence of 
triphenylphosphine and diethyl azodicarboxylate led to complex reaction mixtures, and no desired 

































































































Scheme 1.4 Mitsunobu Reaction of 1.11 to Generate 1.14 
We next turned to activation of the C-15 hydroxyl to a leaving group that could be 
displaced with a nucleophilic azide source.  Treatment of 1.11 with stoichiometric thionyl chloride 
in refluxing pyridine led to none of the desired chloride 1.15; only starting material was recovered. 
Excess thionyl chloride led to complex reaction mixtures and no desired chloride product 1.15 
was isolated (Scheme 1.5).   
 
Scheme 1.5 Attempts to Synthesize Chloride 1.15 
 When 1.11 was treated with methanesulfonyl chloride in pyridine at low temperatures, the 
desired C-15 mesylate 1.16 could be isolated in modest yield (Scheme 1.6).  When 1.16 was 
treated with sodium azide in N,N-dimethylformamide, no reaction was observed.  As this lack of 
reactivity may have been due to the poor solubility of the sodium azide, tetrabutylammonium 
azide was also used.  At lower temperatures, no reaction was observed.  Elevating the 
temperature led to complex mixtures of products, and the desired azide 1.17 was not isolated.   




















































































































1.4  Formation of a Triflate Intermediate Leads to Unexpected Intramolecular 
Cyclization  
 Although the activated C-15 mesylate 1.16 (Scheme 1.6) could be selectively 
synthesized in the presence of the C-11 and C-12 hydroxyls, it was not sufficiently reactive to be 
displaced by an azide source. We next turned to synthesizing the more reactive triflate 
compound, 1.18 (Scheme 1.7). To this end, 1.11 was treated with triflic anhydride and pyridine at 
low temperature. Although 1.18 was observed in crude reaction mixtures, it could not be isolated. 
Along with 1.18, small quantities of 1.19 were observed, and then isolated and characterized. We 
envisioned that the cyclized product 1.19 could arise via the intermediacy of 1.18 in which the C-
12α hydroxyl effects intramolecular displacement of the C15β triflate to generate the novel ring 
system of 1.19.  A similar intramolecular displacement has been reported for a tosylate derivative 
of an octahydrophenanthranol.21  
 
Scheme 1.7 Synthesis of Triflate 1.18 Leads to Intramolecular Cyclization Product 1.19 
The structural assignment of 1.19 is supported by the coupling constant of the C-15 
hydrogen (Figure 1.3). In 1.11, J=12.6 Hz for the C-15α hydrogen corresponding to the trans 
diaxial relationship of C-15α and C-14β hydrogens, respectively, while in 1.19, J=4.9 Hz, which is 



























































respectively.  Additionally, an nOe correlation is observed between C-15α and C-9α hydrogens in 
1.11, which is replaced by a new nOe correlation between the C-15β hydrogen with C-7β and C-
14β hydrogens, respectively, in 1.19.   
 
Figure 1.3. Key nOe Correlations of 1.11 and 1.19 
 The cyclization could be promoted by first forming the intermediate triflate 1.18 at 0 °C 
and then warming the reaction mixture to 25 °C to increase the reaction yield of 1.19 from 8 to 
65%. As illustrated in the conformations shown in Figure 1.3, we observed that the novel 
hexacyclic structure 1.19 retains a similar overall orientation to that of 1.11.  We next sought to 
probe the importance of the orientation of the ester side chain on the modified bruceantin core by 
generating a C-11 acylated analog of 1.19.  Acylating the remaining free C-11 hydroxyl with the 
brusatol side chain would lead to an analog where the side chain is oriented to the back of the 
structure versus the front of the structure as in the natural product 1.2 (Figure 1.1).   
Treatment of 1.19 with 3,3-dimethylacryloyl chloride and catalytic 4-N,N-
dimethylaminopyridine generated 1.20 in 47% yield. Deprotection of 1.20 with 













































Scheme 1.8 Synthesis of Analog 1.21 
1.5  Alternate Protecting Group Strategy  
 After generating analog 1.21 based on the novel cyclization scaffold, we returned to our 
attempts to generate the C-15 amide analog 1.5 (Figure 1.2).  Because cyclized product 1.19 was 
arising from intramolecular reaction of the C-12 hydroxyl, we expected that protecting this group 
would allow intermolecular displacement of the C-15 triflate with an exogenous azide source.  
Although silyl protecting groups were too bulky to be incorporated, 1.2 could be tris protected by 
treatment with methoxymethyl chloride and N,N-diisopropylethylamine to give 1.22 in 71% yield 
(Scheme 1.9).  Unfortunately, the C-15 ester side chain of 1.22 could not be cleaved.  Treating 
1.22 with the conditions used to generate 1.11 (Scheme 1.2) led to no reaction.  Heating gave 
complex reaction mixtures.  Lithium hydroxide and sodium methoxide treatment were also 
unsuccessful.  
 




































































































1.6  Biological Results  
In the Robertson laboratory, 5000 Raji cells were treated with bruceantin (1.1) and cyclized 
analog 1.21 and then incubated for 72 hours. They were then analyzed using the CellTiter-Glo kit.  
Cells treated with 1.1 gave a 10-fold decrease in fluorescence, while cells treated with 1.21 gave 
no detectable change.22 This result demonstrates the importance of the orientation of the side 
chain; it must be oriented to the front of the molecule rather than the back.  Alternatively, 1.1 
could serve as a pro-drug wherein the side chain aids in transport across the cellular membrane9 
and then is cleaved to generate the active drug 1.24 (Figure 1.4).  If this is the case, either 
changing the orientation of the side chain prevents cellular penetration or the alcohol 1.25 derived 
from C-11 side chain cleavage of 1.21 results in inactive compounds (Figure 1.4).   
 
 
































































2. Proposed Method for the Synthesis of the BCE Ring System of 
Bruceantin 
 In addition to its biological activity, bruceantin is a very structurally interesting molecule 
and has been the subject of many synthetic studies since its isolation. Bruceantin contains a 
pentacyclic core, including a bridged tetrahydrofuran and lactone moiety. It is highly oxygenated 
and contains ten contiguous stereocenters, including two quaternary centers. We next turned our 
attention toward the development of a method that could be used for the synthesis of the natural 
product with particular focus on the efficient generation of the bridged tetrahydrofuran-containing 
CE ring system (Figure 2.1).     
 
Figure 2.1 Bruceantin, 1.1, with the CE Ring System Highlighted in Blue 
2.1   Previous Synthetic Studies of the Quassinoids 
In 1989, Sasaki and Murae reported a formal synthesis of (-)-bruceantin from 2.1, which 
was derived from naturally occurring brusatol (Scheme 2.1).23 Direct oxidation of C-15 of 2.1 
could not be achieved, and so a multistep process was undertaken. The lactone was reduced, 
and the resulting intermediate lactol was dehydrated to generate 2.2, which was epoxidized and 
opened in situ to generate 2.3.  Following C-15 esterification, C-16 oxidation, and global 



























Scheme 2.1 Formal Synthesis of Bruceantin from 2.1 
The authors also disclosed the synthesis of racemic 2.1 in fifty-four steps starting from 
the Wieland-Miescher ketone.24,25 E-Ring formation was achieved by ring-opening of an epoxide 
with the C-8 alcohol, obtained via deprotection of 2.4 (Scheme 2.2).   
 
 
Scheme 2.2 Sasaki and Murae’s Formation of the E ring  
The first total synthesis of (±)-bruceantin was reported in 1993 by Grieco and co-workers, 
nearly twenty years after the reported isolation.26 Starting from the previously reported tricyclic 
ketone 2.6, available in eight steps from 2-carbomethoxycyclohexanone,27 bruceantin was 
synthesized in thirty-six steps (Scheme 2.3). Construction of the bridged tetrahydrofuran E ring 
was accomplished through bromination of intermediate 2.7 to generate 2.8.  The authors had 
previously discovered in model studies that compounds such as 2.8 could be transformed to 




















































































Scheme 2.3 Grieco’s Total Synthesis of (±)-Bruceantin 
In the following year, Fuchs et al. published a synthesis of 2.14, which lacks only the C-
15 hydroxyl and side-chain that are present in bruceantin (Scheme 2.4).30 The absolute 
stereochemistry of 2.11 was set with an enantioselective Robinson annulation31 of β-tetralone 
2.10 with a chiral benzylamine to deliver intermediate 2.12 in 95% ee. The tetrahydrofuran bridge 
was formed by treating ketone 2.12 with cyanide anion to generate the cyanohydrin that reacted 
with the pendant C-8 mesylate to deliver 2.13.   
 





















































OMe 1. (R)-α-methyl benzylamine,
toluene, Δ;







































Watt and co-workers developed an enantioselective synthesis of the ABCD ring system 
of the quassinoids starting from the R-(-) enantiomer of the Wieland-Miescher ketone, 2.15 
(Scheme 2.5).32 In 12 steps, including a radical cyclization of bromide 2.18, 2.19 was obtained, 
albeit with the opposite stereochemistry to that required for bruceantin at C-9. This intermediate 
was later used in the total synthesis of 2.20, (+)-picrasin B, a quassinoid that lacks the E ring.33  
 
Scheme 2.5 Watt’s Synthesis of the ABCD Ring System 
Shing et al. published an enantiospecific synthesis of a pentacyclic quassinoid skeleton 
from (+)-carvone, 2.21 (Scheme 2.6).34 The CE ring system was formed in 10 steps35 to generate 
2.22 which was subsequently converted to 2.23.  Upon heating in toluene, the key Diels-Alder 
reaction proceeded smoothly to generate 2.24 in quantitative yield.  Further elaboration 

























































Scheme 2.6 Shing’s Synthesis of the Quassinoid Skeleton 
Deslongchamps et al. have reported a double Michael addition of enones and Nazarov 
reagents to generate cyclic products.36 Treating β-keto-cyano enone 2.26 with Nazarov reagent 
2.27 and base, tricyclic product 2.28 was obtained (Scheme 2.7).37 This tricyclic compound 
contains the ABC ring system of the quassinoids.  
 
Scheme 2.7 Deslongchamps’ Synthesis of the ABC Skeleton 
Maimone et al. developed a copper-catalyzed coupling reaction sequence to synthesize 
the core of the quassinoids starting from carvone epoxide, 2.29 (Scheme 2.8).38 In this approach, 
copper(I) catalyzed double addition of a dioxane-based Grignard reagent 2.31 to a vicinal epoxy 
vinyl triflate, 2.30, led to the formation of 2.32 as a single diastereomer.  A series of cyclizations 



















































Scheme 2.8 Maimone’s Synthesis of the ABC Skeleton 
 
2.2  A Homologous Pauson-Khand Approach to the BCE Ring System of 
Bruceantin  
Although much work has been focused on approaches to the synthesis of members of the 
quassinoid family and of bruceantin in particular, an enantioselective synthesis has yet to be 
reported. We therefore sought to address this challenge as well as to develop a more efficient 
method for the construction of bruceantin, with particular focus on the assembly of the bridged 
tetrahydrofuran-containing CE ring system of 1 (highlighted in blue, Figure 2.1 page 12).  
We envisioned that the CE ring system 2.36 (Scheme 2.9) could result from enone 2.37, 
which could be formed from a formal [3+2+1] cyclization of three carbons of a bridged moiety of 
2.38 (blue) with a pendant alkyne (pink) and carbon monoxide (red). The three-carbon bridge of 
2.38 could be envisioned to arise from the bridged metallacyclobutane 2.39, which would be 
derived via oxidative addition of a metal to the central, and presumably most reactive, carbon-


































































Scheme 2.9 Retrosynthetic Analysis of Bridged Tetrahydrofuran 
 This proposed [3+2+1] cyclization (2.40 to 2.37) using carbon monoxide is similar to the 
Pauson-Khand (PK) reaction, which is a formal [2+2+1] cycloaddition of an alkene, an alkyne, 
and carbon monoxide to generate a cyclopentenone, 2.41 (Figure 2.2).39 Although the 
intramolecular PK reaction is very broad in its scope, the intermolecular reaction is more limited.40 
In the homologous Pauson-Khand (HPK) reaction, the alkene is replaced with a three-membered 
ring, which serves as a three-carbon unit to generate cyclohexenones, 2.43, rather than 
cyclopentenones. Various classes of HPK substrates, including cyclopropanes, cyclopropenes, 
alkylidene cyclopropanes and vinyl cyclopropanes, have been reported. Our proposed method, 
based on the exploitation of the highly strained central bond of a bicyclic ring system as indicated 
in 2.40 represents a novel class of HPK substrates that contain a two atom bridge that could lead 
to an efficient approach to the synthesis of  bridged cyclohexenones such as 2.37.  
 





















Figure 2.2 Comparison of the Pauson-Khand Reaction, the Homologous Pauson-Khand 
Reaction and the Proposed Method 
 
2.3  The Homologous Pauson-Khand Reaction 
In 1999, Narasaka et al. published the first example of a HPK reaction using simple 
cyclopropanes (Scheme 2.10).41 When 4-pentynyl cyclopropanes such as 2.41 were treated with 
rhodium(I) dicarbonyl chloride dimer under a carbon monoxide atmosphere, bicyclo[4.3.0] 
nonenones such as 2.42 were generated along with small quantities of the corresponding 
oxidation product 2.43. This formation of 2.42 was rationalized via the mechanism shown in 
Scheme 2.10. Oxidative addition of the cyclopropane, 2.41, to the rhodium complex gave 
metallacyclobutane 2.44, which underwent insertion of the pendant alkyne to generate 2.45.  
Carbon monoxide insertion and reductive elimination then gave cyclohexenone product 2.42.  
Although the reaction occurred at atmospheric pressures of carbon monoxide, high pressures (4 
atm) were typically required to suppress formation of side products. 
C O







Homologous-Pauson Khand Reaction, [3+2+1]








Scheme 2.10 Narasaka’s HPK Reaction of Cyclopropanes 
 In addition to high pressures of carbon monoxide, high catalyst loading, elevated 
temperatures, and long reaction times (48-120 h) were required, which limited the synthetic utility 
of the reaction.  To address these limitations, we report herein the study of substrates with 
increased ring strain relative to cyclopropane.   
In 2010, Wang et al. reported the use of cyclopropenes such as 2.46 as the three carbon 
unit of the HPK reaction to yield phenol 2.47 (from pendant alkynes) or enone 2.48 (from pendant 
alkenes) (Scheme 2.11).42 The proposed mechanism is similar to that of the cyclopropanes.  
Oxidative addition of the σ bond of the cyclopropene to rhodium leads to the formation of 
metallacycle 2.49.  The pendant unsaturated moiety then undergoes insertion to form 2.50, which 
subsequently undergoes insertion of carbon monoxide to give intermediate 2.51.  Alternatively, 
insertion of carbon monoxide could proceed first, followed by alkyne or alkene insertion to 
generate 2.51, which on reductive elimination would lead to the formation of 2.47 or 2.48. Good 
trans diastereoselectivity was observed in the case of the alkenes. The reaction of the more 
strained cyclopropene substrates (54.5 vs. 29 kcal mol-1)43 occurred at lower temperatures with 
lower catalyst loading at atmospheric pressures of carbon monoxide. Only symmetrically 



























Scheme 2.11 HPK Reaction of Cyclopropenes 
In addition to cyclopropenes, alkylidene cyclopropanes are also sufficiently strained (40.9 
kcal mol-1)43 to undergo metal insertion. In 2012 Evans et al. reported a stereoselective rhodium-
catalyzed [3+2+1] cyclization of alkylidene cyclopropanes such as 2.52 to give bicyclohexenones 
such as 2.54 (Scheme 2.12).44 The authors used Density Functional Theory (DFT) calculations to 
support the proposal that product formation occurs via addition of cationic rhodium(I) distal to the 
unsaturation to generate metallacycle 2.55, which undergoes rearrangement to metallacycle 2.56.  
Insertion of the pendant alkene into 2.56 generates 2.57, which, following carbon monoxide 
insertion and reductive elimination, leads to the formation of intermediate 2.53 that isomerizes to 
the enone 2.54.  Kim and Chung have developed a similar method using pendant alkynes to 





































Scheme 2.12 HPK Reaction of Alkylidene Cyclopropanes 
Vinylcylopropanes, although significantly less strained than cyclopropenes or 
alkylidenecyclopropanes,43 can be used as substrates induced through activation of the initial π-
coordination of rhodium and C-C bond cleavage to generate π-allylrhodacycles (2.59, Scheme 
2.13).  The resulting metallacycle can then undergo reaction as either a five-carbon unit (2.60) or 
a three-carbon unit (2.61).   
 
Scheme 2.13 Rhodacycles Generated from Oxidative Addition of Vinylcyclopropanes 
Wender et al. published the first [5+2+1] cyclization of alkoxy-substituted 
vinylcyclopropanes in 2002 (Scheme 2.14A).46 Methoxy vinylcyclopropanes such as 2.62 
underwent reaction with carbonyl-substituted alkynes such as 2.63.  Cyclization of the resulting 
product 2.64, followed by hydrolysis, led to bicyclo[3.3.0]octenone products such as 2.65. The 































was expanded to intramolecular alkenes such as 2.66 to synthesize cyclooctenones 2.67 
(Scheme 2.14B).47    
 
Scheme 2.14 [5+2+1] Cyclization of Vinylcyclopropanes  
Yu and co-workers have reported rhodium(I) catalyzed [3+2+1] cyclizations of 
vinylcyclopropanes with alkene or alkyne tethers to generate cyclohexanone or cyclohexenone 
products, respectively (Scheme 2.15).48 In this case, the vinyl moiety of 2.68 acts only as an 
activating group and is not incorporated in the cyclization to 2.69.  
 
Scheme 2.15 HPK Reaction of Vinylcyclopropanes 
 Unstrained cyclopropanes can also undergo [3+2+1] cyclizations if a directing group is 
used. Bower et al. have reported [3+2+1] cyclizations of aminocyclopropanes such as 2.70 
directed by a nitrogen protecting group to generate bicyclohexenones such as 2.71 (Scheme 
2.16).49 The insertion of rhodium is directed into the σ-bond proximal to the amine by the urea 
group, and, following carbon monoxide insertion, generates rhodacyclopentanone 2.72.  


































intermediate 2.73. Alkyne insertion and reductive elimination then generate 2.71. The urea group 
is required to outcompete initial coordination with the alkyne and direct the insertion.  When less 
strongly coordinating alkene partners are used, weaker directing groups, such as carbamates, 
can be employed.50   
 
Scheme 2.16 HPK of Amino Cyclopropanes 
In summary, cyclopropenes, alkylidene cyclocyclopropanes, vinylcyclopropanes, and 
simple cyclopropanes (with directing groups or under forcing conditions) have all been shown to 
































Figure 2.3. Known HPK Reactions of Various Classes of Cyclopropanes 
Our proposed method represents an important extension of the HPK reaction to generate 
bridged, bicyclic ring systems via strained fused bicyclic precursors. Using heteroatom-containing 
bicyclo[2.1.0]pentanes such as 2.74 as strained substrates, we propose to generate bridged 
bicyclic systems such as 2.75 (Figure 2.4). The ring strain of the proposed [2.1.0] ring systems is 
similar to that of cyclopropene (~54 kcal mol-1)43 and thus should be sufficient to promote the 
initial metal insertion.  
 





































Alkylidenecyclopropanes 40.9 kcal mol-1
Activated cyclopropanes ~30 kcal mol-1









3. Synthesis of Bicyclo[2.1.0]pentane Substrates 
Although the proposed method introduced in Chapter 2 was inspired by the natural 
product bruceantin, we were first interested in obtaining proof of concept on a simpler substrate 
as well as in determining a general cyclization protocol that could be applied to a range of 
substrates (Scheme 3.1).  Typically, the PK and HPK reactions are most efficient and widely used 
in an intramolecular reaction, while the intermolecular reaction requires specific alkene substrates 
that limit the overall scope.40 For this reason, we envisioned that the proposed substrates should 
have the alkyne moiety tethered to the bicyclo[2.1.0]pentane, although the tether could be 
attached at any atom. Varying tether links (m=1-2) could give rise to 6,5- or 6,6-fused rings. 
Although X=O in the case of bruceantin, we proposed to study the all-carbon substrate as well as 
the nitrogen-containing substrate. Expanding the substrate from a bicyclo[2.1.0]pentane to a 
bicyclo[3.1.0]hexane (n=1 vs. 2), although a significantly less strained ring system (54.7 vs. 31.0 
kcal mol-1),51 and thus presumably more challenging in the proposed reaction sequence, would 
further broaden the scope of the process. All of these variables are included in generic substrate 
3.1, which would undergo HPK reaction to generate product scaffold 3.2, which is present in a 
number of natural products, some of which are shown in Figure 3.1.  The first goal of this work 
was to develop general and efficient syntheses of substrates such as 3.1.   
 

















Figure 3.1. Natural Products Containing Bridged Heterosubstituted Polycyclic Systems 
 
3.1  Known Routes to Azabicyclo[2.1.0]pentanes 
 We decided to target the azabicyclo[2.1.0]pentane substrates first because of the high 
ring strain and added valency of the nitrogen atom that could be used to modulate the reactivity of 
the strained ring system, as well as serving as a possible tether for the incorporation of directing 
groups, if necessary (i.e., Bower’s work, Chapter 2.3).  At the outset of the project, only a few 
examples of azabicyclo[2.1.0]pentanes were known. The naturally occurring amino acid, 2-
azabicyclo[2.1.0]pentane-3-(S)-carboxylic acid SF-1836 (Figure 3.2), was isolated from 
Streptomyces zaomyceticus and exhibits antimicrobial activity.52    
 


























































 In 1985, Merck patented antibiotic scaffolds based on the azabicyclo[2.1.0] core structure 
3.5 (Scheme 3.2).53 The azabicyclo[2.1.0] system was constructed by treating the β-lactam 
substrate 3.3 with base to generate the enolate, which displaced a pendant tosylate to provide 
3.4 in modest yield.   
  
Scheme 3.2 Synthesis of Azabicyclo[2.1.0] Antibiotics 
 During the course of our work, in 2017, Kimura et al. published the synthesis of 
azabicyclo[2.1.0]pentanes by intramolecular nucleophilic substitution (Scheme 3.3).54 1-
Chlorocyclopropyl p-tolyl sulfoxide esters 3.8 were generated from α,β-unsaturated esters such 
as 3.6 and dichloromethyl p-tolyl sulfoxide, 3.7.  In three steps, 1-chlorocyclopropyl p-tolyl 
sulfoxide-2-aminomethyl-aryl substrates 3.10 were formed. The amine was deprotonated with 
tert-butylmagnesium chloride, and then isopropylmagnesium chloride effected 
sulfoxide/magnesium exchange to give intermediate 3.12.  Upon warming to -20 °C, the chloride 
was displaced by the nitrogen anion and, following a quench with ammonium chloride, 






















Scheme 3.3 Kimura’s Synthesis of Azabicyclo[2.1.0]pentanes 
 Although procedures for the synthesis of azabicyclo[2.1.0]pentanes were known, it was 
unclear that these methods would allow the efficient incorporation of the pendant alkyne moiety 
necessary to generate substrates such as 3.1 (Scheme 3.1).  For this reason, we sought to 
develop a new route to azabicyclo[2.1.0]pentanes.    
 
3.2  Hydrazones as Carbene Precursors 
We first thought to synthesize the azabicyclo[2.1.0]pentanes such as 3.15 from the 
intramolecular cyclopropanation of a carbene with an appropriately substituted alkene, 3.16 
(Scheme 3.4A).  At the outset, we targeted a simpler carbene intermediate 3.17, lacking the 
pendant alkynyl chain to determine the viability of this approach for the generation of substrates 









































































Scheme 3.4 (A) Retrosynthetic Analysis of Azabicycylo[2.1.0]pentane 3.15 and (B) A Model 
Azabicyclo[2.1.0]pentane 3.18 
Cyr et al. have published a transition-metal-free synthesis of tertiary aminocyclopropanes 
using tosyl hydrazones as carbene precursors (Scheme 3.5).55 When tosyl hydrazones 3.19, 
derived from the corresponding amides, were treated with lithium bis(trimethylsilyl)amide and 
heated, the in situ generated carbene reacted with styrene to generate aminocyclopropane 
products 3.20.  In most cases, R1 was an aryl group, but one example was given with an ester 
substituent (3.21 to 3.22).  One intramolecular example was also presented where, rather than 
adding styrene, a pendant alkene of 3.23 reacted with the in situ generated carbene to give a 
bicyclo[3.1.0]hexane, 3.24.  We wondered whether a similar substrate truncated by one carbon 






















Scheme 3.5 Synthesis of Aminocyclopropanes from Tosyl Hydrazones 
 The preparation of substrate 3.29, lacking the alkyne tether, is outlined below (Scheme 
3.6). Known compound 3.27 was N-alkylated with allyl bromide to give 3.28, which was then 
activated with triflic anhydride and base before being treated with p-toluenesulfonyl hydrazide to 
deliver hydrazone substrate 3.29, albeit in modest yield.   
 
Scheme 3.6 Synthesis of Hydrazone Substrate 3.29 
 Treatment of tosyl hydrazone 3.29 with lithium bis(trimethylsilyl)amide and heat did not 
generate any of the desired azabicyclo[2.1.0]pentane product 3.31 (Scheme 3.7).  Although 
starting material was consumed, the new product retained the vinyl proton peaks in the 1H NMR 













































































situ generated diazo compound 3.32 reacting with itself and then losing an equivalent of nitrogen 
gas. Cyr et al. report a similar dimerization product when an electron-rich arene was used in the 
place of styrene.55 The reaction was repeated at a ten-fold dilution and the same product was 
observed, although it formed at a slower rate (12 hours vs. 1 hour). Other bases failed to deliver 
3.31, instead leading to no reaction, the formation of 3.30, or the formation of intractable mixtures 
of products.  We hypothesized that although the diazo intermediate may be forming in situ, the 
ring strain of the desired [2.1.0] system is too high to obtain the desired product from this 
intermediate.   
 
Scheme 3.7 Attempts to Synthesize Azabicyclo[2.1.0]pentane 3.31 
3.3  Kulinkovich-de Meijere Reaction 
 Another common method for the synthesis of aminocyclopropanes is the Kulinkovich de-
Meijere reaction.56 When treated with two equivalents of a Grignard reagent 3.35 in the presence 
of stoichiometric titanium(IV) isopropoxide, N,N-dialkylamides 3.34 react to deliver the substituted 
aminocyclopropane 3.36 (Scheme 3.8A). If the Grignard reagent used is cyclohexyl- or 





















































incorporated into the product (Scheme 3.8B).57 This modification allows the stoichiometric use of 
the alkene rather than sacrificing an equivalent of the alkene as a Grignard reagent.   
 
Scheme 3.8 Kulinkovich De-Meijere Reaction 
The mechanism of the Kulinkovich de-Meijere reaction is shown in Scheme 3.9. The 
titanium(IV) species is alkylated by the Grignard reagent to form the alkyltitanium intermediate 
3.38, which undergoes β-hydride elimination to generate titanacyclopropane 3.39 which is 
proposed to be in equilibrium with the corresponding titanium-cyclopentene complex 3.40. The 
required olefin 3.37 exchanges with the cyclopentene ligand to give the new titanacyclopropane 
3.41. Reaction of 3.41 with the amide gives oxatitanacyclopentane 3.42, which is opened to 
zwitterionic intermediate 3.43 via iminium ion formation. Aminocyclopropane 3.36 is then formed 
from intramolecular ring closure.  
 


















































This reaction has been used in an intramolecular fashion to generate azabicyclo[3.1.0] 
hexanes such as 3.45 from N,N-dialkylacetamide 3.44 (Scheme 3.9A).58 We sought to investigate 
whether this intramolecular reaction could be used for the synthesis of azabicyclo[2.1.0]pentanes 
such as 3.47 by using substrates truncated by one carbon, such as 3.46 (Scheme 3.9B).   
  
Scheme 3.10 (A) Known Intramolecular Kulinkovich De-Meijere Reaction; (B) Proposed 
Intramolecular Kulinkovich De-Meijere Reaction 
Both the phenyl and benzyl nitrogen-protected substrates (R=Ph and PhCH2, 
respectively) 3.48 and 3.49 were prepared using known procedures59,60 and tested as substrates 
with the Kulinkovich de-Meijere conditions (Scheme 3.11). In all cases attempted, none of the 
desired azabicyclo[2.1.0]pentane products 3.50 or 3.51 were observed.  The only products to be 
isolated from the reactions were secondary amides 3.52 or 3.53, in which the starting materials 
have lost the allyl group.  We hypothesized that the Grignard reagent may be attacking the allyl 
group in an SN2’ fashion to deliver 3.52 or 3.53 or that the allyl group was being reductively 
cleaved by the titanium. Preforming titanacyclopropane 3.40 (Scheme 3.9) before adding the 
amide substrate could allow consumption of the nucleophilic Grignard reagent. Premixing the 
chlorotriisopropoxytitanium(IV) and the cyclopentylmagnesium bromide in an attempt to preform 
3.40 for ligand exchange at lower temperatures (-78°C to 0°C) led to de-allylated products 3.52 or 






















be because the cyclopentene ligand is dissociating from 3.40 to generate Ti(OiPr)2, which is an 
unreactive intermediate.61  
 
Scheme 3.11 Attempts to Synthesize Azabicyclo[2.1.0]pentanes Via Intramolecular 
Kulinkovich De-Meijere Reaction 
3.4  β-Lactams as [2.1.0] Precursors 
 Because of the challenges of closing to the azabicyclo[2.1.0]pentane from a linear 
system, we turned to the previously described approach utilizing intramolecular ring closure of β-
lactams onto a pendant tosylate (Scheme 3.2). We sought to investigate whether this strategy 
could be modified to synthesize substrates bearing the required pendant alkyne at the bridgehead 
position (Scheme 3.12). Enolate formation of 3.55, substituted at the α position, should lead to 
displacement of the pendant tosylate to generate 3.54. We reasoned that alkylation of the dianion 
of a compound such as 3.56, available in enantiopure form from an amino acid derivative,62 would 
deliver 3.55.   
 
Scheme 3.12 Retrosynthetic Analysis Using b-Lactam Substrate 
 L-Aspartic acid dibenzyl ester was converted into the β-lactam ester 3.57 in two steps 
following a known procedure (Scheme 3.13).63 Reduction of the ester gave the alcohol 3.56 that 




































with p-toluenesulfonyl chloride delivered the tosylate 3.55.  Gratifyingly, when 3.55 was treated 
with lithium bis(trimethylsilyl)amide, the generated enolate displaced the tosylate to give the 
desired [2.1.0] system 3.54 in good yield.   
  
Scheme 3.13 Synthesis of [2.1.0] Substrate 3.54 
 Although the route shown in Scheme 3.13 delivered the desired [2.1.0] product, the low 
yield of the alkylation step (3.56 to 3.59) made it difficult to obtain sufficient quantities of 3.54 for 
testing in the proposed HPK reaction.  Along with desired product 3.59, the silyl-transferred 
product 3.60, wherein the tert-butyldimethylsilyl moiety was transferred from the nitrogen to the 
oxygen atom, was isolated (Table 3.1, entry 1). Warming the temperature of the reaction from -78 
°C to 0 °C to promote alkylation led to the exclusive formation of 3.60 in 43% yield (entry 2). 
Although 3.60 could be converted to 3.59, the two steps required for oxygen deprotection and 
nitrogen protection made the route quite long, and so attempts were made to optimize the 
selective formation of 3.59. Shorter reaction times led to very low conversions (entries 3-4).  
Using diethyl ether as the solvent returned only starting material, even with warming to 0 °C, 
possibly because of poor substrate solubility (entry 5). Using the more reactive alkyl triflate gave 
















































Entry X Base Solvent Temperature (ºC) Time (h) % Yield 3.59 % Yield 3.60 
1 I LDA THF -78 7 15 10 
2 I LDA THF -78 to 0 2 -- 43 
3 I n-BuLi THF -78 2 <5 -- 
4 I LDA THF -78 to 0 2 <5 -- 
5 I LDA Et2O -78 to 0 6 -- -- 
6 OTf LDA THF -78 1.5 32 -- 
Table 3.1. Attempted Optimization of Alkylation Product 3.57 
 
An alternate protecting group was explored because of the difficulties of forming 3.59 in 
synthetically useful yields. Unfortunately, when the nitrogen was protected with a benzyl group, 
alkylation of the dianion of 3.61 occurred on the benzyl carbon rather than the α carbon to give an 
inseparable mixture of diastereomers 3.62 (Scheme 3.14) 
 
Scheme 3.14 Alkylation with Benzyl Protecting Group 
Even the known bis-silyl-protected substrate 3.6364 underwent alkylation in only modest 



























high overall step count and poor atom economy of the route shown in Scheme 3.13 necessitated 
the continued exploration for other, more efficient routes to the required azabicyclo[2.1.0]pentane 
substrates.   
 
Scheme 3.15 Alkylation of Bis-Silyl Protected 3.63 
3.5  Hydroxyproline as a [2.1.0] Precursor 
 Although β-lactam precursors allowed the synthesis of the desired substrate 3.54, the 
alkylation step to incorporate the pendant alkyne was low yielding, and the high step count and 
poor atom economy made it difficult to obtain sufficient quantities of 3.54 for screening in the HPK 
reaction.  Exploring the literature for the synthesis of the all-carbon bicyclo[2.1.0]pentanes led to a 
report by Hall et al. in which chlorocylopentane 3.65 closed to bicyclo[2.1.0]pentane 3.68 when 
treated with sodium hydride (Scheme 3.16).65   
 
Scheme 3.16 Synthesis of an All Carbon Bicyclo[2.1.0]pentane 3.66 
In the synthesis of C3-N1’ heterodimeric indolines from bromopyrroloindoline 3.67, 
Espejo and Rainier proposed a transiently formed cyclopropane 3.68, which reacted with a 



















publication, the authors showed that this intermediate cyclopropane 3.66 could be isolated 
(Scheme 3.17B).67    
 
Scheme 3.17 A) Synthesis of Heterodimeric Indolines, B) Isolation of 
Cyclopropylazetoindoline 
  Based on the combined work of Hall and Rainier, we sought to investigate whether the 
intramolecular displacement of the bromide of a proline-derived substrate lacking an indole ring 
could occur to generate azabicyclo[2.1.0]pentanes. The required bromide 3.71 was synthesized 
in three steps from commercially available trans-4-hydroxy-L-proline (Scheme 3.18).  Conversion 
of the acid to the methyl ester and nitrogen protection delivered alcohol 3.70, which underwent an 
Appel reaction to generate 3.71 with inversion of stereochemistry at C-4.68  
 


















































 With bromide 3.71 in hand, a variety of bases were screened in an attempt to generate 
azabicyclo[2.1.0]pentane 3.72 (Table 3.2). Rainier’s potassium tert-butoxide conditions returned 
starting material at low temperatures and led to complex reaction mixtures at elevated 
temperatures (entry 1).  Hall’s sodium hydride conditions also failed to deliver the desired [2.1.0] 
product (entry 2).  When lithium diisopropylamide was employed, desired product 3.72 was 
isolated in 36% yield (entry 3). Using lithium bis(trimethylsilyl)amide increased the yield to 52%.  
Sodium bis(trimethylsilyl)amide was also used but gave a lower yield of 39% (entry 5).   
 
Entry Base Solvent % Yield 3.72 
1 KOtBu THF -- 
2 NaH DMF -- 
3 LDA THF 36 
4 LiHMDS THF 52 
5 NaHMDS THF 39 
Table 3.2 Base Screen to Deliver 3.72 
 
 The intramolecular displacement of the bromide to generate 3.72 using lithium 
bis(trimethylsilyl)amide was found to be scalable. Gradually increasing the scale from one 
millimole of 3.71 substrate (52%) up to twenty millimoles of 3.71 delivers a 68% yield of 3.72, 
allowing the synthesis of 3.72 in multigram quantities.   
In addition to the efficient delivery of substantial quantities of the desired 
azabicyclo[2.1.0]pentane 3.72, it was envisioned that this route would produce the 
azabicyclo[2.1.0]substrate in enantiopure form, as it utilized an amino acid-derived starting 









treated with base to generate 3.72 (Scheme 3.19).  When the optical rotations of the two 
substrates derived from trans- and cis-4-hydroxy-L-proline were measured, values of +180.0 and 
-191.2 were obtained, respectively. Thus, both optical series of compound 3.72 were available. It 
was expected that the stereochemistry of 3.72 was set by an SN2 displacement of the bromide by 
the enolate anion, although crystallographic data would be necessary to confirm the absolute 
stereochemistry of the products.  
 
Scheme 3.19 Synthesis of (-)-3.72 from cis-4-Hydroxy-L-proline 
Although cis-4-hydroxy-L-proline is commercially available, it is much more expensive 
than the trans isomer ($60-600/g vs <$1/g).  Because of this, it would be desirable to be able to 
obtain both optical series from trans-4-hydroxy-L-proline (Scheme 3.20).  Treatment of alcohol 
3.70 with p-toluenesulfonyl chloride delivered tosylate 3.73 with retention of stereochemistry at C-
4, which when treated with lithium bis(trimethylsilyl)amide led to intramolecular displacement of 
the tosylate to give (-) 3.72 as evidenced by its optical rotation (-160.4).     
 
Scheme 3.20 Synthesis of (-) 3.72 from trans-4-Hydroxy-L-proline 
With a reliable route to both optical series of the azabicyclo[2.1.0]pentane core, 
incorporation of the pendant alkyne was investigated (Scheme 3.21).  Reduction of the ester of 
3.72 using diisobutylaluminum hydride delivered the alcohol 3.74, which could be alkylated with 







































Scheme 3.21 Incorporation of Pendant Alkyne 
In conclusion, two routes to the desired azabicyclo[2.1.0]pentane HPK substrates were 
developed.  Both utilize amino acid starting materials and deliver enantiopure substrates.  
Although the route based on β-lactam precursors gave poor yields in the key alkylation step, the 
route starting from trans-4-hydroxy-L-proline delivered reasonable quantities of HPK substrate 
3.75 in six steps and 32% overall yield. Additionally, in this route the requisite alkyne was 
incorporated in the final step, allowing the expedient synthesis of a range of substrates to test the 

















4. Rhodium Results 
With azabicyclo[2.1.0]pentane substrates in hand, we began examining rhodium-
catalyzed conditions to deliver the desired HPK reaction.   
4.1 Evaluation of β-Lactam Substrate 3.54 in the HPK Reaction 
When substrate 3.54 was treated with di-µ-chloro-tetracarbonyldirhodium(I) under an 
atmosphere of carbon monoxide and heated, starting material was consumed in one hour 
(Scheme 4.1). None of the desired HPK product 4.1 was observed; instead, product 4.2 was 
isolated. Product 4.2 was also formed at lower temperature (40 °C). Cationic bis(1,5-
cyclooctadiene)rhodium(I) tetrafluoroborate also delivered product 4.2 at 25 °C in one hour in 
83% yield.   
 
Scheme 4.1 Evaluation of Substrate 3.54 
 Compound 4.2 is proposed to arise via the mechanism shown in Scheme 4.2.  Oxidative 
addition of rhodium to the strained central carbon-carbon bond of the bicyclic ring system delivers 
intermediate rhodacycle 4.3, which undergoes β-hydride elimination to compound 4.4.  Reductive 
elimination of the rhodium-hydride gives compound 4.2.  At some unknown stage in the 
mechanism, the tert-butyldimethylsilyl protecting group on the nitrogen is lost, and the free 
secondary amide is formed.  Although there was no incorporation of carbon monoxide or any 
evidence of the pendant alkyne insertion into the intermediate rhodacycle 4.3, formation of 
product 4.2 provides proof of concept for the initially proposed oxidative addition.  The strain of 






















Scheme 4.2 Proposed Mechanism for the Formation of 4.2 
In their report on the HPK reaction of aminocyclopropanes, Bower et al. reported a 
product that arises via a similar mechanism (Scheme 4.3).49 The model substrate 4.5, which lacks 
a pendant alkyne, was shown to undergo oxidative addition to generate rhodacycle 4.6. β-Hydride 
elimination gave rhodium hydride 4.7, and reductive elimination delivered enamine 4.8.   
 
 
Scheme 4.3 Bower’s Control Experiment 
 Although encouraged by the results that provide proof of concept for the oxidative 
addition of the strained central carbon-carbon bond, for reasons discussed in Chapter 3, it was 
difficult to synthesize sufficient material to screen various conditions adequately to promote 
alkyne or carbon monoxide insertion of substrate 3.54. Thus, we turned our attention to 


















































4.2  Evaluation of Hydroxyproline-Derived Substrate 3.75 in the HPK Reaction 
 Encouraged by the evidence that the rhodium was indeed inserting into the strained 
central carbon-carbon bond of the azabicyclo[2.1.0]pentane substrates, we continued to evaluate 
the HPK reaction on the more readily available substrate 3.75.  When 3.75 was treated with 
chloro(1,5-cyclooctadiene)rhodium(I) dimer and heated under an atmosphere of carbon 
monoxide, two new products were observed (Scheme 4.4).  The two products could not be 
separated chromatographically but have been tentatively assigned the structures 4.9 and 4.10.  
These products showed no incorporation of carbon monoxide as evidenced by mass 
spectrometry; the respective 1H NMR spectrum contain vinyl protons and retained the alkynyl 
carbons in the 13C NMR spectrum.   
 
Scheme 4.4 Evaluation of Substrate 3.75 
 The same products were observed under argon atmosphere and at low temperature (23 
°C). As alkenes have also been shown to participate in the HPK reaction, the alkenyl substrate 
4.11 was also synthesized by alkylating 3.74 with allyl bromide (Scheme 4.5).   
 
Scheme 4.5 Synthesis of Substrate 4.11 
When the alkenyl compound 4.11 was treated with di-µ-chloro-tetracarbonyldirhodium(I) 
under a carbon monoxide atmosphere, products 4.12 and  were generated (Scheme 4.6).  These 
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ring-opened products could be separated and characterized, supporting the structural assignment 
of the alkynyl products 4.9 and 4.10 (Scheme 4.4).   
 
Scheme 4.6 Evaluation of Substrate 4.11 
The ring-opened products are proposed to arise via the mechanism shown in Scheme 
4.7. The rhodium inserts into the strained central carbon-carbon bond to generate rhodacycle 
4.14. Rather than insertion of either carbon monoxide or the pendant alkene, the rhodacycle 
rearranges to the carbene intermediate 4.15 (path a).  A 1,3-hydride shift then delivers 4.16, and 
reductive elimination gives the product 4.12.  Rhodacycle 4.14 can also undergo rearrangement 
to carbene intermediate 4.17 (path b), which leads to the formation of the observed product 4.13.   
 
Scheme 4.7 Proposed Mechanism for the Formation of 4.12 and 4.13 
 A similar mechanism has been proposed by Wipf and co-workers with a 
bicyclo[1.1.0]butane substrate (Scheme 4.8).69 The rhodium inserts into the central strained 
carbon-carbon bond of 4.18 to generate rhodacycle 4.19.  After a screen of several 
catalyst/ligand systems, the authors found that a di-µ-chloro-tetracarbonyldirhodium(I)/1,2-






















































carbene intermediate 4.20. This selectivity was attributed to the bulky, bidentate ligand.  Rather 
than a 1,3-hydride shift, the resulting carbene intermediate 4.20 underwent cyclopropanation with 
the pendant alkene to deliver seven-membered ring product 4.21. If a chlorobis(ethylene)rhodium 
dimer/ triphenylphosphine system was used, path b was favored to generate the more stable 
internal carbene intermediate 4.22. This carbene intermediate also underwent cyclopropanation 
with the pendant alkene to deliver the five-membered ring product 4.23.  
 
Scheme 4.8 Wipf’s Cycloisomerization of Bicyclo[1.1.0]butane  
 Because the β-lactam substrate 3.54 delivered product 4.2 derived from a β-hydride 
elimination mechanism (Scheme 4.2), and the hydroxyproline-derived substrate 4.11 delivered 
products 4.12 and 4.13 derived from rearrangement to carbene intermediates, we sought to 
investigate the role of the electron-withdrawing group on the course of the reaction. A control 
substrate lacking the pendant unsaturated moiety was synthesized by alkylating alcohol 3.74 with 
methyl iodide to generate ether 4.24 (Scheme 4.9).  
 









































  When methyl ether substrate 4.24 was treated with di-µ-chloro-tetracarbonyldirhodium(I) 
at 23 °C, ring-opened products 4.25 and 4.26 were formed (Scheme 4.10A).  These products 
were derived exclusively from the rearrangement mechanism (as in Scheme 4.7). When the ester 
substrate 3.72 was treated with di-µ-chloro-tetracarbonyldirhodium(I) at 23°C, no reaction was 
observed. When the reaction mixture was heated to 80 °C for twenty-four hours, products 4.27-
4.30 were formed along with 20% recovered starting material (Scheme 4.10B). All products are 
proposed to arise via initial insertion of rhodium into the strained central carbon-carbon bond.  
Products 4.27 and 4.28 arise from β-hydride elimination and reductive elimination of the resulting 
rhodacyle (as in Scheme 4.2). Pyrrole 4.29 may result from air oxidation of 4.27 and 4.28 during 
isolation. Ring-opened product 4.30 is obtained via rearrangement of the initially formed 
rhodacycle to a carbene intermediate followed by 1,3-hydride shift and reductive elimination (as in 
Scheme 4.7). The major pathway is the β-hydride elimination, as only a small amount (10%) of 
4.30 was formed.   
 
Scheme 4.10 Control experiments of Hydroxyproline Derived Substrates 
 Based on these results, we hypothesize that the electron-withdrawing group may be 
stabilizing the intermediate rhodacycle to suppress the unproductive rearrangement to carbene 
intermediates (as in Scheme 4.7).  Although the β-hydride elimination pathway also delivers an 














































could promote the insertion of the pendant alkyne and carbon monoxide prior to the undesired β-
hydride elimination. However, because the rearrangement to carbene intermediates occurs even 
at 23 °C in the substrates lacking the electron-withdrawing group, we reasoned that it would be 
exceedingly challenging to preclude this mechanistic pathway with these substrates. Subsequent 
studies therefore would focus on substrates bearing an electron-withdrawing group.  The 
preparation of the requisite substrates could be accomplished by either developing a more 
efficient route to 3.54 or by modifying the hydroxyproline route to retain the ester functional group 





5. Evaluation of Palladium Catalysis 
Although treatment with rhodium catalysts delivered undesired ring-opened products via 
rearrangement to carbene intermediates, we were encouraged by the observation of the initial 
oxidative addition of rhodium to the strained cyclopropane ring.  With an efficient route developed 
to these strained, reactive substrates, we sought to engage them in other transition-metal 
catalyzed processes.  We sought to investigate reactions with a metal that would allow the initial 
oxidative addition to the central strained carbon-carbon bond but without the subsequent carbene 
formation.  The known palladium catalyzed [3+2] cyclizations of cyclopropane substrates70 
inspired us to test our substrates in this type of reaction.   
 
5.1  [3+2] Cycloadditions of Cyclopropyl Substrates 
In addition to use as substrates in the HPK reaction, strained cyclopropanes also 
undergo metal-catalyzed [3+2] cyclizations. In seminal work by Noyori et al. in 1970, 
methylenecyclopropane 5.1 was treated with nickel catalyst in excess methyl acrylate, and 3-
methylenecyclopentanecarboxylate 5.3 was obtained in 82% yield (Scheme 5.1A).71 This type of 
reaction was expanded to the use of palladium catalysts by Binger and Schuchardt (Scheme 
5.1B).72 Upon treatment of 5.1 with palladium catalyst and methyl acrylate (5.2), cycloaddition 







Scheme 5.1 Nickel- and Palladium-Catalyzed [3+2] Cycloadditions of 
Methylenecyclopropane 
 
In 1988 Shipman et al. extended this method to the intramolecular reaction of 
diphenylmethylenecyclopropanes such as 5.5 to generate bicyclo[3.3.0]octanes such as 5.6 
(Scheme 5.2A).73 This method was later used to generate the more synthetically useful 
unsubstituted exo-methylene-containing compounds such as 5.8 from methylenecyclopropanes 
such as 5.7 (Scheme 5.2B).74 An electron-withdrawing substituent on the alkyne was required for 
the reaction to proceed.   
 
Scheme 5.2 Shipman’s [3+2] Cycloaddition of (A) Diphenylmethylenecyclopropanes and 













































In 1994 Lautens et al. published an intramolecular stereocontrolled palladium-catalyzed 
[3+2] cycloaddition of methylenecyclopropanes (Scheme 5.3).75 When 5.9 or epi-5.9 was treated 
with palladium catalyst, bicyclo[3.3.0]octenes 5.10 or epi-5.10 were formed as single 
diastereomers. X-Ray analysis of derivatives of 5.10 confirmed that the reaction proceeded 
stereospecifically with overall retention of stereochemistry.  
 
Scheme 5.3 Lautens’ Stereocontrolled [3+2] Cycloaddition of Methylenecyclopropanes 
The proposed mechanism for the formation of 5.10 is shown in Scheme 5.4. The 
palladium first coordinates to the alkyne of 5.9.  Next, insertion into the distal C-C bond gives 
metallacycle 5.11, which then inserts the pendant alkyne to deliver 5.12. These steps most likely 
both occur with retention of stereochemistry,76 but a double inversion is also possible. Following 
reductive elimination, bicyclo[3.3.0]octane 5.10 is formed. 
 




















































In the previous examples, the alkyne is attached to one of the cyclopropane carbons of a 
methylenecyclopropane. In 2003, Mascareñas et al. published the palladium-catalyzed [3+2] 
cyclization of alkylidene cyclopropanes in which the alkyne is tethered to the alkylidene moiety 
(Scheme 5.5).77 Alkylidene substrates 5.14 were treated with palladium catalyst and phosphite 
ligand to deliver bicyclo[3.3.0]octanes 5.15.  Unlike the previous examples, the alkyne did not 
require an electron-withdrawing substituent to undergo reaction. This method was later expanded 
to an enantioselective procedure by utilizing a chiral phosphoramidite ligand to deliver the 
bicyclo[3.3.0] octanes in up to 94% ee.78  
 
Scheme 5.5 Mascareñas’ [3+2] Cycloaddition of Alkylidenecyclopropanes 
 
5.2  Palladium-Catalyzed Reaction of Azabicyclo[2.1.0]pentanes 
Using the azabicyclo[2.1.0]pentane compounds of the type 5.16 designed in Chapter 3 as 
[3+2] cycloaddition substrates would give rise to bridge compounds such as 5.17.  
 
Scheme 5.6 Proposed [3+2] Cycloaddition of Azabicyclo[2.1.0]pentanes 
Although Mascareñas was able to avoid the need for electron-withdrawing substituents 
on the alkyne, other laboratories had shown it to be essential, and so substrate 5.19 was 























with propargyl bromide delivered 5.18, which was then deprotonated using lithium 
diisopropylamide and treated with methyl chloroformate to deliver substrate 5.19. 
 
Scheme 5.7 Synthesis of Substrate 5.19 
When 5.19 was treated with tris(dibenzylideneacetone)dipalladium(0) and triisopropyl 
phosphite, rather than the expected [3+2] product 5.20, spirocyclic product 5.21 was isolated in 
50% yield.  
 
Scheme 5.8 Results of Palladium Catalysis 
We propose that this spirocyclic product arises via the mechanism shown in Scheme 5.9.  
Oxidative addition of the most strained central carbon-carbon bond of 5.19 to palladium 
generates palladacycle 5.22. Insertion of the pendant alkyne gives 5.23. Rather than a reductive 
elimination from 5.23 to generate [3+2] product 5.20, β-hydride elimination occurs to deliver 5.24.  
Presumably the β-hydride elimination is favored over the reductive elimination because of the ring 
strain of the resulting norbornene product 5.20. From 5.24 a reductive elimination of the palladium 





































Scheme 5.9 Proposed Mechanism for the Formation of 5.21  
Although this product was unexpected, we were nonetheless interested in this novel 









































Entry Catalyst Ligand Solvent Temp (ºC) Time % Yield 
1 10% Pd2(dba)3 40% P(OiPr)3 toluene 80 1 h 50 
2 10% Pd2(dba)3 40% P(OiPr)3 toluene 110 10 min 41 
3 10% Pd2(dba)3 20% BINAP toluene 80 6 h -- 
4 10% Pd2(dba)3 40% P(OiPr)3 1,4-dioxane 80 1 h 77 
5 10% Pd2(dba)3 40% P(OtBu)3 1,4-dioxane 80 2 h 44 
6 10% Pd2(dba)3 40% L1 1,4-dioxane 80 30 min 62 
7 10% Pd2(dba)3 40$ L1 1,4-dioxane 25 4 h 71 
8 10% Pd2(dba)3 40% L1 THF 25 6 h 66* 
9 2% Pd2(dba)3 8% L1 1,4-dioxane 25 24 h 78* 
10 2% Pd2(dba)3 8% L1 1,4-dioxane 60 3 h 87 
*Yield based on 1,3,5-trimethyoxybenzene internal standard 
Table 5.1 Optimization Table of Palladium-Catalyzed Spirocyclization 
 
The initial reaction conditions used 10% catalyst loading with 40% triisopropyl phosphite 
ligand in toluene to deliver 5.21 in 50% yield (entry 1). Increasing the temperature to reflux 
decreased the reaction yield to 41% yield (entry 2).  Using 20 mol % of the bidentate phosphine 
ligand 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl gave no reaction (entry 3), demonstrating the 
need for phosphite rather than phosphine ligands. Using 1,4-dioxane as solvent improved the 
yield to 77% (entry 4). Use of the bulkier tri-(tert-butyl) phosphite ligand lowered the yield to 44% 
(entry 5). Tris(1,1,1,3,3,3-hexafluoropropan-2-yl) phosphite (L1) led to a slightly diminished yield, 


















yield at 25 °C (no reaction was observed using triisopropyl phosphite at 25 °C).  Tetrahydrofuran 
also delivered product, but in a slightly diminished yield (entry 8). The catalyst loading could be 
lowered to 2% without a deleterious effect on the yield but the lower catalyst loading required 
longer reaction times (entry 9). The sluggish reaction time could be overcome by warming the 
reaction to 60 °C for three hours to deliver 5.21 in 87% isolated yield (entry 10).  
With optimized conditions in hand, we wished to investigate the stereospecificity of the 
reaction. In order to do so, a chromophore was necessary for analysis. Both (+)- and (-)-5.25 
containing a benzyl ester were synthesized from (+)- and (-)-5.18, respectively (Scheme 5.9).  
These compounds were mixed in a 1:1 molar ratio to create a racemic standard and analyzed by 
supercritical fluid chromatography (SFC). Both (+)- and (-)-5.25 were then analyzed individually 
by SFC to confirm that each was enantiopure (>99% ee).  
 
Scheme 5.10 Synthesis of Benzyl Ester Substrates (+)- and (-)-5.25 
 
The racemic mixture was then subjected to the palladium-catalyzed conditions to deliver 
a racemic mixture of the spirocyclic product (±)-5.26 as confirmed by SFC analysis (Scheme 
5.11).  In a separate reaction, (+)-5.25 was subjected to the palladium-catalyzed conditions to 
deliver (+)-5.26 in 98.6% ee as determined by SFC.  Both the initial oxidative addition and the 
























observed by Lautens et al.75 However, an x-ray structure of a derivative of (+)-5.26 would be 
necessary to confirm the absolute stereochemistry of the product. These experiments are 
ongoing.    
  
Scheme 5.11 Determination of Stereospecificity 
 
5.3  Future Goals 
Having both optimized the conditions for the palladium-catalyzed spirocyclization of the 
azabicyclo[2.1.0]pentane substrates and determined the stereospecificity of the reaction, the next 
goal of these studies is to establish the scope of this reaction (Figure 5.1). Substrates of the 
generic type 5.27 could undergo reaction to form spirocyclic products of the type 5.28.  To 
establish the scope of this reaction, we will determine the role of the nitrogen protecting group 
(R1).  Presently it is unknown whether the ring strain of the azabicyclo[2.1.0]pentane system is 
sufficient to promote the initial metal insertion or if the tert-butyl carbamate plays an important role 
as a directing group (in analogy to Bower’s work, Scheme 2.16).  Replacing the tert-butyl 
carbamate with a non-coordinating protecting group such as benzyl would allow this factor to be 
determined.  The necessity of the electron-withdrawing group on the alkyne (R2) will also be 




























Incorporating other atoms into the tether (X = NH, CH2, etc.) would further increase the synthetic 
utility of this method. Elongating the tether linker (n = 2), which would depend on the efficient 
insertion of the metal catalyst into a less strained sigma bond, would allow the formation of 5,6-
spirocycles.  The synthesis of some of these substrates is outlined below.    
 
Figure 5.1 Proposed Substrate Scope 
The tert-butyl carbamate group of 5.18 was removed with trifluoroacetic acid to give the 
free secondary amine. (Scheme 5.12) Reductive amination of the secondary amine with 
benzaldehyde delivered benzyl protected compound 5.29. This intermediate could next be 
deprotonated and treated with methyl chloroformate to give substrate 5.30 bearing an electron-
withdrawing group. Analysis of the results obtained with this substrate will establish whether the 
tert-butyl carbamate group serves as a directing group (in analogy to Bower’s work, Scheme 
2.16) or if the strain of the azabicyclo[2.1.0]pentane system is sufficient to promote the initial 
metal insertion.   
 

































The syntheses of terminal alkyne 5.18 and methyl alkyne 3.75 have been previously 
discussed (Schemes 5.7 and 3.21, respectively). Phenyl alkyne 5.31 was also synthesized by 
alkylating alcohol 3.74 with 3-bromo-1-phenylpropyne (Scheme 5.13).  
 
Scheme 5.13 Synthesis of Substrate 5.31 
 The inverse alkynyl ester substrates 5.32 and 5.33 were synthesized by coupling alcohol 
3.74 with propiolic acid and 2-butynoic acid, respectively, in the presence of N,N-
dicyclohexylcarbodiimide and 4-dimethylaminopyridine (Scheme 5.14).   
 
Scheme 5.14 Synthesis of Substrates 5.32 and 5.33 
Finally, alcohol 3.74 was converted to propargylamine 5.34 by treatment with Mitsunobu 
conditions utilizing N-tosylpropargylamine (Scheme 5.15). The propargylamine was deprotonated 
and treated with methyl chloroformate to generate substrate 5.35.   
  














































 These and other substrates will be treated with the optimized palladium-catalyzed 
conditions described above for the generation of spirocyclic products to determine the generality 




6. Experimental Methods 
General Methods 
Solvents used for extraction and purification were HPLC grade from Fisher. Unless otherwise 
indicated, all reactions were run under an inert atmosphere of argon. Anhydrous 
dichloromethane, tetrahydrofuran, ethyl ether and toluene were obtained via passage through an 
activated alumina column. Commercial reagents were used as received. VWR pre-coated silica 
gel plates (250 µm, 60 F254) were used for analytical TLC. Spots were visualized using 254 nm 
ultraviolet light, with potassium permanganate stain as the visualizing agent. Chromatographic 
purifications were performed on Sorbent Technologies silica gel (particle size 32-63 microns). 1H 
and 13C NMR spectra were recorded at 500 MHz and 125 MHz, respectively, in CDCl3 or DMSO-
d6 on a Bruker AM-500 or DRX-500 spectrometer. Chemical shifts are reported relative to internal 
chloroform (δ 7.26 for 1H, δ 77.0 for 13C) or DMSO (δ 2.50 for 1H, δ 39.52 for 13C). Infrared 
spectra were recorded neat using a Perkin-Elmer Spectrum Two Fourier transform spectrometer. 
Accurate mass measurement analyses were conducted on either a Waters GCT Premier, time-of-
 flight, GCMS with electron ionization (EI), or an LCT Premier XE, time-of-flight, LCMS with 
electrospray ionization (ESI). Samples were taken up in a suitable solvent for analysis. The 
signals were mass measured against an internal lock mass reference of perfluorotributylamine 
(PFTBA) for EI-GCMS, and leucine enkephalin for ESI-LCMS. Waters software calibrates the 
instruments, and reports measurements, by use of neutral atomic masses. The mass of the 
electron is not included.  Melting points were obtained on a Thomas Hoover capillary melting 







To a solution of 1.11 (122.8 mg, 0.22 mmol) in 0.22 mL pyridine at 0°C under argon was added 
dropwise methane sulfonyl chloride (43 µL, 0.53 mmol).  After 2 hours at 0°C, the reaction was 
concentrated and then redissolved in 5 mL CH2Cl2 and washed sequentially with 2x2 mL 1M aq. 
HCl and then 1x2 mL brine.  The combined organics were dried over MgSO4, filtered and 
concentrated in vacuo.  The resulting residue was purified by flash chromatography on silica gel 
eluting with 1 to 5% CH3OH/CH2Cl2 to afford 31.7 mg (23%) 1.16 as a white film.   Rf=0.50 (5% 
CH3OH/CH2Cl2) 
 
1H NMR (500 MHz, CD3OD) δ 6.22 (d, J = 12.9 Hz, 1H), 4.88 (s, 1H), 4.70 (d, J = 7.6 Hz, 1H), 
4.23 (t, J = 1.7 Hz, 1H), 4.17 (dd, J = 4.9, 1.6 Hz, 1H), 3.79 (s, 3H), 3.74 (dd, J = 7.7, 1.7 Hz, 1H), 
3.26 (dd, J = 13.0, 1.8 Hz, 1H), 3.17 (s, 3H), 3.00 – 2.95 (m, 1H), 2.79 (d, J = 15.9 Hz, 1H), 2.55 – 
2.47 (m, 1H), 2.32 – 2.25 (m, 1H), 2.19 (dd, J = 4.9, 1.6 Hz, 1H), 1.87 (d, J = 1.8 Hz, 4H), 1.36 (d, 
J = 1.1 Hz, 3H), 0.95 (s, 9H), 0.13 (d, J = 25.8 Hz, 6H). 
13C NMR (126 MHz, CD3OD) δ 195.01, 172.00, 169.02, 145.94, 139.01, 84.96, 82.71, 76.40, 
75.85, 74.53, 72.82, 53.20, 52.89, 51.22, 47.12, 43.82, 42.57, 41.60, 40.00, 30.06, 26.53, 19.69, 
15.77, 14.79, -3.40, -3.64. 
FT-IR (cm-1): 2955, 2930, 1736, 1668, 1640, 751 






































To a solution of 1.11 (158.6 mg, 0.29 mmol) in 0.3 mL pyridine at 0°C under argon atmosphere 
was added triflic anhydride (53 µL, 0.32 mmol) in 0.3 mL CH2Cl2.  Upon consumption of starting 
material by TLC (30% EtOAc/CH2Cl2), the reaction was warmed to 25oC.  After 24h, the mixture 
was diluted with 5mL chloroform, washed sequentially with 5mL deionized water, 5 mL 2N HCl, 
and 5 mL brine.  The combined organics were dried over MgSO4, filtered, and concentrated in 
vacuo.  The resulting residue was purified by flash chromatography on silica gel eluting with 5% 
EtOAc/CH2Cl2 to afford 100.2 mg (65%) of 1.19 as a white foam.  Rf=0.45 (30% EtOAc in CH2Cl2)     
 
1H NMR (500 MHz, CDCl3): δ 4.87 (1H, dd, J=4.0, 2.0 Hz), 4.83 (1H, d, J=8.8 Hz), 4.65 (1H, d, 
J=4.9 Hz), 4.41 (1H, d, J=4.3 Hz), 4.16 (1H, dt, J=12.2, 4.8 Hz), 4.00 (1H, dd, J=8.9, 2.0 Hz), 3.87 
(3H, s), 3.66 (1H, d, J=12.3 Hz), 3.16 (1H, d, J=4.9 Hz), 3.04-2.96 (1H, m) 2.90 (1H, d, J=16.1 
Hz), 2.43 (1H, dt, J=14.9, 3.5 Hz), 2.31-2.22 (1H, m), 1.91 (1H, dd, J=5.1, 1.9 Hz), 1.84 (3H, t, 
J=2.3), 1.68 (1H, ddd, J=15.3, 13.1, 2.3 Hz), 1.32 (3H, s), 0.94 (9H, s), 0.15 (6H, d, J=5.5 Hz) 
13C NMR (126 MHz, CDCl3): 191.8, 168.9, 168.7, 145.6, 134.7, 88.9, 83.3, 79.5, 74.5, 73.0, 71.5, 
56.7, 53.5, 50.7, 46.8, 43.5, 42.7, 41.0, 30.6, 26.2, 19.0, 15.5, 14.0, 3.7  
FT-IR (cm-1): 3500, 1741.12, 1672.16, 1276.39 









































To a solution of 1.19 (30 mg, 0.056 mmol) and DMAP (4.8 mg, 0.056 mmol) in CH2Cl2 (1.1 mL) 
under argon atmosphere was added dropwise 3,3-dimethylacryloyl chloride (62 µL, 0.56 mmol). 
After being stirred at 25oC for 18h, the reaction mixture was poured into a solution of saturated 
aqueous NaHCO3 (2 mL) and extracted with CHCl3 (3x15mL). The combined organic extracts 
were washed with brine (2 mL), dried over MgSO4, and concentrated in vacuo.  The resulting 
residue was purified by column chromatograpy eluting with 2% EtOAc/CH2Cl2 to afford 16.4mg 
(47%) 1.20 as a white film.   Rf=0.65 (30% EtOAc in CH2Cl2) 
 
1H NMR (500 MHz, CDCl3): δ 5.63 (p, J = 1.3 Hz, 1H), 5.19 (t, J = 4.8 Hz, 1H), 4.90 – 4.81 (m, 
2H), 4.63 (dd, J = 11.9, 4.6 Hz, 2H), 3.98 (dd, J = 8.4, 2.1 Hz, 1H), 3.82 (s, 3H), 3.13 (d, J = 4.9 
Hz, 1H), 3.02 (d, J = 13.0 Hz, 1H), 2.52 (d, J = 15.9 Hz, 1H), 2.42 (dt, J = 14.7, 3.5 Hz, 1H), 2.28 
(d, J = 16.0 Hz, 1H), 2.18 (d, J = 1.2 Hz, 4H), 1.90 (d, J = 1.3 Hz, 3H), 1.83 (d, J = 2.0 Hz, 3H), 
1.68 (ddd, J = 15.2, 13.1, 2.2 Hz, 1H), 1.22 (s, 3H), 0.94 (s, 9H), 0.13 (d, J = 5.1 Hz, 6H). 
13C NMR (500 MHz, CDCl3): δ191.8, 169.5, 168.9, 165.1, 160.0, 145.4, 135.1, 115.1, 87.4, 84.1, 
78.0, 73.7, 72.7, 69.8, 57.0, 53.3, 50.4, 46.6, 43.8, 41.5, 40.9, 30.5, 27.2, 26.2, 20.6, 19.0, 15.4, 
14.1, -3.7 
FT-IR (cm-1): 1741.72, 1673.73, 1245.95 




































To a solution of 1.20 (15.1 mg, 0.024 mmol) in tetrahydrofuran (0.5 mL) under argon atmosphere 
was added a tetrabutylammonium fluoride solution (1.0 M in tetrahydrofuran, 37 µL, 0.037 mmol), 
and the mixture was stirred at 25oC for 20min.  The mixture was diluted with chloroform (30 mL), 
washed sequentially with 5mL deionized water and 5mL brine, and then dried over Na2SO4, 
filtered and concentrated in vacuo.  The crude residue was purified by flash column 
chromatography 1:10 EtOAc:CH2Cl2 to afford 3.9 mg (32%) of 1.21 as a white film.  Rf=0.50 (30% 
EtOAc in CH2Cl2) 
 
1H NMR (500 MHz, CDCl3) δ 6.05 (s, 1H), 5.64 (t, J = 1.3 Hz, 1H), 5.22 (t, J = 4.8 Hz, 1H), 4.91 – 
4.82 (m, 2H), 4.64 (dd, J = 17.9, 4.6 Hz, 2H), 3.99 (d, J = 2.1 Hz, 1H), 3.83 (s, 3H), 3.15 (d, J = 
4.9 Hz, 1H), 3.04 (d, J = 13.0 Hz, 1H), 2.60 (d, J = 16.4 Hz, 1H), 2.43 (dd, J = 14.7, 3.5 Hz, 1H), 
2.35 (d, J = 16.4 Hz, 1H), 2.26 – 2.18 (m, 4H), 1.90 (d, J = 1.3 Hz, 3H), 1.84 (d, J = 2.0 Hz, 3H), 
1.72 – 1.65 (m, 1H), 1.23 (d, J = 1.1 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 191.85, 169.49, 168.79, 165.11, 160.19, 144.47, 127.18, 115.04, 
87.39, 83.97, 78.04, 73.72, 72.74, 69.75, 57.06, 53.32, 48.62, 46.71, 43.07, 41.58, 41.48, 30.23, 
27.70, 20.64, 15.44, 13.11. 
FT-IR (cm-1): 2924.44, 1669.53, 1644.13, 1224.53 




































To a solution of 1.2 (70%) (1.0 g, 1.92 mmol) in 9.6 mL 1,2-dichloroethane at 0°C under argon 
was added 3.4 mL N,N-diisopropylethyl amine (19.5 mmol, 10eq) and 0.73 mL MOMCl (9.6 
mmol, 5 eq) dropwise, The resulting reaction was warmed to 45°C and stirred until starting 
material is consumed based on thin layer chromatography (3% CH3OH/CH2Cl2).  The reaction 
was cooled to 25°C, diluted with 10 mL chloroform, and 4 mL deionized water added; layers were 
separated and the resulting aqueous layer was extracted 2x 10mL chloroform; the combined 
organic layers were then washed 1x10 mL brine, dried over MgSO4, filtered and concentrated in 
vacuo.  The crude residue was purified by flash column chromatography 1:99 CH3OH:CH2Cl2 to 
afford 796.4 mg (64%) of 1.22 as a white film.  Rf=0.80 (3% CH3OH in CH2Cl2) 
 
1H NMR (500 MHz, CDCl3) δ 6.04 (s, 1H), 5.64 (s, 1H), 4.98 (d, J = 6.3 Hz, 1H), 4.94 (d, J = 6.3 
Hz, 1H), 4.82 (dd, J = 12.3, 6.5 Hz, 3H), 4.71 (d, J = 6.7 Hz, 1H), 4.65 (d, J = 7.5 Hz, 1H), 4.51 (d, 
J = 6.4 Hz, 1H), 4.44 (s, 1H), 4.16 – 4.12 (m, 1H), 3.74 (s, 3H), 3.69 (d, J = 7.6 Hz, 1H), 3.50 (s, 
3H), 3.42 (s, 3H), 3.36 (s, 4H), 2.97 (d, J = 12.9 Hz, 1H), 2.86 (d, J = 15.7 Hz, 1H), 2.43 – 2.35 
(m, 1H), 2.30 (d, J = 15.7 Hz, 1H), 2.18 (d, J = 1.3 Hz, 3H), 2.13 (s, 1H), 1.92 (dd, J = 4.4, 1.5 Hz, 
6H), 1.82 – 1.73 (m, 1H), 1.36 – 1.29 (m, 3H). 
13C NMR (126 MHz, CDCl3) δ 192.17, 169.61, 167.75, 159.82, 146.47, 144.63, 114.63, 98.70, 
97.66, 97.46, 82.95, 81.05, 78.15, 77.80, 77.36, 73.35, 66.31, 57.49, 56.52, 56.38, 52.71, 51.01, 
45.01, 43.43, 42.10, 40.40, 29.15, 27.69, 20.60, 15.45, 14.71. 
FT-IR(cm-1): 2951.2, 1744.1, 1671.7, 1439.5, 1301.1, 1152.8 










































To a solution of 3.27 (1.0g, 5.18 mmol) in 10 mL N,N-dimethylformamide at 0°C under argon 
atmosphere was added allyl bromide (0.47 mL, 5.43 mmol).  Sodium hydride (60% dispersion in 
mineral oil, 217.2 mg, 5.43 mmol) was added portion-wise.  After addition, the reaction was 
warmed to 22°C and stirred 4 hours. The reaction was cooled to 0°C and quenched with the slow 
addition of 10 mL of a saturated aqueous solution of ammonium chloride.  Deionized water (10 
mL) was added and the reaction was extracted with ethyl acetate (3x30 mL).  The combined 
organic layers were washed with deionized water (2x20 mL), dried over Na2SO4, filtered and 
concentrated in vacuo.  The resulting residue was purified by flash chromatography on silica gel 
eluting with 20% EtOAc/Hex to afford 721.4 mg (60%) of 3.28 as colorless oil.  Rf=0.6 (40% 
EtOAc/Hex).   
 
1H NMR (500 MHz, CDCl3) δ 7.37 – 7.26 (m, 5H), 5.75 (dddt, J = 16.5, 12.5, 10.1, 6.0 Hz, 1H), 
5.25 (ddq, J = 15.4, 10.1, 1.4 Hz, 1H), 5.17 (ddq, J = 22.8, 17.1, 1.5 Hz, 1H), 4.60 (s, 1H), 4.43 (s, 
1H), 3.94 – 3.84 (m, 4H), 3.77 (dt, J = 5.9, 1.5 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ [163.42, 163.26], [161.94, 161.72], [135.72, 135.12], [132.16, 
131.23], [128.96, 128.88], [128.49, 128.30], [127.95, 127.93], [119.40, 119.04], [52.77, 52.71], 
[50.70, 49.56], [46.87, 45.92]. 
FT-IR(cm-1): 2968.4, 1742.6, 1656.9, 1360.8 





















To a solution of 3.28 (233.3 mg, 1 mmol) in 5 mL 1,2-dichloroethane at 0°C under argon 
atmosphere was added triflic anhydride dropwise (0.18 mL, 1.1 mmol) followed by 2-methoxy 
pyridine (0.14 mL, 1.3 mmol).  The reaction was warmed to 22°C and stirred for 10 minutes and 
then p-toluenesulfonyl hydrazide (279.3 mg, 1.5 mmol) was added in one portion.  The reaction 
was stirred for 6 hours at 22°C and then 10 mL of a saturated aqueous NaHCO3 solution was 
added.  The reaction was extracted with CH2Cl2 (3x30 mL), dried over MgSO4, filtered and 
concentrated in vacuo.  The resulting residue was purified by flash chromatography on silica gel 
eluting with 20% EtOAc/CH2Cl2 to afford 90.5 mg (23%) of 3.29 as a colorless oil.  Rf=0.3 (40% 
EtOAc/CH2Cl2).       
 
1H NMR (500 MHz, CDCl3-d) δ 7.75 – 7.69 (m, 2H), 7.33 – 7.26 (m, 3H), 7.26 – 7.23 (m, 1H), 
7.23 – 7.16 (m, 3H), 6.58 (d, J = 2.0 Hz, 1H), 5.69 (ddt, J = 17.2, 10.2, 6.0 Hz, 1H), 5.17 (dq, J = 
10.1, 1.3 Hz, 1H), 5.09 (dq, J = 17.0, 1.5 Hz, 1H), 4.34 (s, 2H), 3.89 (s, 3H), 3.67 (dt, J = 6.1, 1.5 
Hz, 2H), 2.41 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 162.25, 159.71, 143.86, 136.11, 134.94, 132.12, 129.35, 128.75, 
128.62, 128.03, 127.77, 118.86, 52.88, 50.69, 50.25, 21.73. 
FT-IR (cm-1): 2997, 1740, 1579, 1362 






















To a solution of 3.29 (100 mg, 0.25 mmol) in 1.66 mL p-xylenes at 23°C under argon atmosphere 
was added dropwise lithium bis(trimethylsilyl)amide (1M in toluene, 0.3 mL, 0.3 mmol).  The 
reaction was then heated to 115°C for 1 hour.  The reaction was cooled and concentrated in 
vacuo.  The resulting residue was purified by flash chromatography on silica gel eluting with 15% 
EtOAc/Hex to afford 9.9 mg (17%) of 3.30 as colorless oil.  Rf=0.6 (40% EtOAc/Hex).   
 
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.25 (m, 5H), 5.83 – 5.72 (m, 1H), 5.16 (dt, J = 10.1, 1.4 Hz, 
1H), 5.10 (dt, J = 17.1, 1.5 Hz, 1H), 4.37 (s, 2H), 3.73 – 3.66 (m, 5H). 
13C NMR (126 MHz, CDCl3) δ 165.00, 155.17, 137.32, 133.12, 128.56, 128.22, 127.40, 118.13, 
51.87, 50.29, 49.73. 




A suspension of sodium borohydride (250.6 mg, 6.63 mmol) in 13.3 mL tetrahydrofuran and a 
solution of lithium bromide (575.4, 6.63 mmol) in 3.4 mL deionized water were combined in an 
addition funnel and added dropwise over 20 min to a solution of 3.57 (849.6 mg, 2.65 mmol) in 





































and then 10 mL of a saturated aqueous solution of ammonium chloride was added and the 
aqueous layer was extracted with ethyl acetate (2x25 mL).  The combined organic layers were 
dried over MgSO4, filtered and concentrated in vacuo.  The resulting crude residue was purified 
by column chromatography eluting with 2:1 Hex/EtOAc to afford 449.6 mg (81%) of 3.56 as a 
clear oil.  Rf=0.2 (2:1 Hex/EtOAc) 
 
1H NMR (500 MHz, CDCl3) δ 3.84 – 3.74 (m, 1H), 3.74 – 3.63 (m, 2H), 3.10 (ddd, J = 15.3, 5.4, 
1.5 Hz, 1H), 2.86 (ddd, J = 15.3, 2.6, 1.4 Hz, 1H), 0.96 (d, J = 1.4 Hz, 9H), 0.24 (dd, J = 10.3, 1.4 
Hz, 6H). 
13C NMR (151 MHz, CDCl3) δ 172.92, 64.82, 50.09, 41.23, 26.34, 18.57, -5.27, -5.54. 
FT-IR(cm-1): 3422.8, 2928.9, 2857.8, 1711.0, 1362.5 
HRMS (ESI) m/z [M+H] calcd for C10H22NO2Si, 216.1420; found: 216.1432 




To diisopropylamine (0.93 mL, 6.6 mmol) in 21 mL tetrahydrofuran at -78°C under argon 
atmosphere was added dropwise a solution of n-BuLi (2.17M in hexanes, 3.0 mL, 6.6 mmol) and 
the mixture stirred for 15 minutes at -78°C.  A solution of 3.56 (646.1 mg, 3.0 mmol) in 6 mL 
tetrahydrofuran was added dropwise over 3 minutes at -78°C.  The mixture was stirred at -78°C 
for 1h and then hex-4-yn-1-yl trifluoro-methanesulfonate (1.381 g, 6.0 mmol) was added dropwise 
in 3 mL tetrahydrofuran.  The reaction was stirred at -78°C for 3h.  The reaction was quenched 
















mixture was extracted with ethyl acetate (2x20 mL) and the combined organic layers were dried 
over MgSO4, filtered and concentrated in vacuo.  The resulting residue was purified by flash 
column chromatography on silica gel eluting from 25 to 50% EtOAc/Hex to afford 280.4 mg (32%) 
of 3.59 as a colorless oil.  Rf= 0.5 (1:2 EtOAc/Hex) 
 
1H NMR (500 MHz, CDCl3) δ 3.79 (dt, J = 9.7, 4.3 Hz, 1H), 3.68 (dd, J = 11.5, 5.6 Hz, 1H), 3.36 
(ddd, J = 6.1, 4.1, 2.4 Hz, 1H), 3.02 (ddd, J = 8.8, 6.0, 2.4 Hz, 1H), 2.17 (ddt, J = 6.9, 4.5, 2.5 Hz, 
2H), 1.88 (ddt, J = 13.5, 9.8, 6.0 Hz, 2H), 1.78 – 1.69 (m, 4H), 1.59 (ddt, J = 16.1, 9.7, 6.8 Hz, 
2H), 0.95 (s, 9H), 0.23 (d, J = 24.9 Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ 176.01, 78.70, 76.27, 64.65, 57.29, 54.10, 28.37, 26.64, 26.36, 
18.74, 18.61, 3.59, -5.19, -5.44. 
FT-IR(cm-1): 3423, 2929, 2858, 1710, 1195 
HRMS (ESI) m/z [M+H] calcd for C16H30NO2Si, 269.2046; found: 296.2059 





To a solution of 3.59 (60.0mg, 0.2mmol) and DMAP (2mg, 0.017mmol) in 1.66mL CH2Cl2 under 
argon atmosphere at 0°C was added tosyl chloride (69.4mg, 0.36mmol) and triethylamine (92µL, 
0.66mmol). The reaction was allowed to warm to 23°C and stirred until starting material was 
consumed as judged by thin layer chromatography (2:1 Hex/EtOAc). The reaction mixture was 
















were dried over MgSO4, filtered and concentrated in vacuo. The resulting residue was purified by 
flash chromatography on silica gel eluting with 2:1 Hexanes:EtOAc to afford 75.2mg (84%) of 
3.55 as a clear oil.  Rf=0.5 (2:1 Hex/EtOAc) 
1H NMR (500 MHz, CDCl3) δ 7.78 (d, J = 8.4 Hz, 2H), 7.39 – 7.32 (m, 2H), 4.13 (dd, J = 10.4, 5.0 
Hz, 1H), 4.00 (dd, J = 10.4, 5.9 Hz, 1H), 3.42 (ddd, J = 5.9, 5.0, 2.4 Hz, 1H), 2.81 (ddd, J = 8.7, 
6.2, 2.4 Hz, 1H), 2.46 (s, 3H), 2.12 (ddt, J = 6.8, 4.4, 2.6 Hz, 2H), 1.87 – 1.78 (m, 1H), 1.76 (t, J = 
2.5 Hz, 3H), 1.72 – 1.62 (m, 1H), 1.56 – 1.45 (m, 2H), 0.91 (s, 9H), 0.18 (d, J = 32.3 Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ 174.60, 145.48, 132.61, 130.16, 128.07, 78.32, 76.38, 70.78, 
55.07, 53.99, 28.04, 26.36, 26.28, 21.82, 18.61, 18.56, 3.59, -5.31, -5.52. 
FT-IR (cm-1): 2929, 2858, 1744, 1189 
HRMS (ESI) m/z [M+H] calcd for C23H36NO4SSi, 472.1954; found: 472.1967 
Optical Rotation: -10.71 (c=0.2, CHCl3, 22°C) 
 (1R,4S)-2-(tert-Butyldimethylsilyl)-4-(hex-4-yn-1-yl)-2-azabicyclo[2.1.0]pentan-3-one 
 
To a solution of 3.55 (59.3 mg, 0.13 mmol) in 1.3 mL tetrahydrofuran at -78°C under argon 
atmosphere was added dropwise a solution of lithium bis(trimethylsilyl)amide (1M in 
tetrahydrofuran, 0.26 mL, 0.26 mmol).  After addition, the reaction was warmed to 0°C and stirred 
for 1 hour.  The reaction was quenched at 0°C with 5mL of a saturated solution of aqueous 
ammonium chloride and the aqueous layer was extracted with CH2Cl2 (3x15mL).  The combined 
organic layers were dried over MgSO4, filtered and concentrated in vacuo.  The resulting residue 
was purified by flash chromatography on silica gel eluting with 10% EtOAc/Hex to afford 27.9mg 
(78%) of 3.54 as a clear oil.  Rf=0.6 (1:2 EtOAc/Hex) 
 
LiHMDS










1H NMR (500 MHz, CDCl3) δ 3.48 (d, J = 2.8 Hz, 1H), 2.23 – 2.17 (m, 2H), 1.93 – 1.79 (m, 3H), 
1.76 (td, J = 2.5, 1.0 Hz, 3H), 1.71 – 1.64 (m, 2H), 1.39 (ddd, J = 4.1, 2.9, 1.0 Hz, 1H), 0.91 (s, 
9H), 0.16 (dd, J = 10.5, 1.1 Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ 175.40, 78.72, 76.05, 38.90, 37.17, 36.03, 27.09, 26.01, 24.51, 
18.59, 17.96, 3.60, -5.44, -5.79. 
FT-IR (cm-1): 2929, 2858, 1744, 1253 
HRMS (ESI) m/z [M+H] calcd for C16H28NOSi, 278.1940; found: 278.1926 




To diisopropylamine (0.15 mL, 1.1 mmol) in 2 mL tetrahydrofuran at -78°C under argon 
atmosphere was added dropwise a solution of n-BuLi (2.5M in hexanes, 0.44 mL, 1.1 mmol) and 
the mixture stirred for 15 minutes at -78°C. A solution of 3.56 (107.7 mg, 0.5 mmol) in 5 mL 
tetrahydrofuran was added dropwise over 3 minutes at -78°C.  The mixture was stirred at -78°C 
for 30 minutes and then iodide 3.58 (208.0 mg, 1.0 mmol) in 2 mL tetrahydrofuran was added 
dropwise over 1 minute.  The reaction was stirred at -78°C for 1 hour, and then warmed to 0°C for 
1 hour.  The reaction was quenched with 10 mL of a saturated aqueous solution of ammonium 
chloride.  The mixture was extracted with ethyl acetate (2x20 mL) and the combined organic 
layers were dried over MgSO4, filtered and concentrated in vacuo.  The resulting residue was 
purified by flash column chromatography on silica gel eluting from 25 to 50% EtOAc/Hex to afford 


















1H NMR (500 MHz, CDCl3) δ 6.02 (s, 1H), 3.73 (dd, J = 10.5, 4.7 Hz, 1H), 3.63 (dd, J = 10.6, 6.5 
Hz, 1H), 3.40 (ddd, J = 6.7, 4.7, 2.2 Hz, 1H), 2.87 – 2.79 (m, 1H), 2.16 (tq, J = 7.1, 2.5 Hz, 2H), 
1.88 (ddt, J = 13.6, 9.9, 6.0 Hz, 1H), 1.78 – 1.66 (m, 4H), 1.59 (ddq, J = 13.1, 9.7, 6.4 Hz, 2H), 
0.88 (s, 9H), 0.05 (s, 6H). 
13C NMR (126 MHz, CDCl3) δ 170.91, 78.48, 76.24, 65.43, 55.86, 53.52, 27.51, 26.89, 25.95, 
18.68, 18.38, 3.56, -5.26, -5.29. 
FT-IR (cm-1): 2929, 2857, 1747, 1252 
HRMS (ESI) m/z [M+H] calcd for C16H30NO2Si, 269.2046; found: 296.2037 




To diisopropylamine (0.15 mL, 1.1 mmol) in 5 mL tetrahydrofuran at -78°C under argon 
atmosphere was added dropwise a solution of n-BuLi (2.5M in hexanes, 0.44 mL, 1.1 mmol) and 
the mixture stirred for 15 minutes at -78°C.  A solution of 3.61 (95.6 mg, 0.5 mmol) in 2 mL 
tetrahydrofuran was added dropwise over 1 minute at -78°C.  The mixture was stirred at -78°C for 
1h and then iodide 3.58 (208.0 mg, 1.0 mmol) in 2 mL tetrahydrofuran was added dropwise over 
1 minute at -78°C.  The reaction was stirred at -78°C for 15min and then warmed to 0°C for 
30min.  The reaction was quenched with 10 mL of a saturated aqueous solution of ammonium 
chloride.  The mixture was extracted with ethyl acetate (2x20 mL) and the combined organic 
















The resulting residue was purified by flash column chromatography on silica gel eluting from 1:1 
to 2:1 EtOAc/Hex to afford 71.7 mg (53%) of 3.62 as a clear oil. Rf= 0.5 (2:1 EtOAc/Hex). 
 
1H NMR (500 MHz, CDCl3) δ 7.39 – 7.27 (m, 5H), [4.64 (dd, J = 9.0, 6.5 Hz, 0.7H); 4.55 (dd 
J=9.2, 6.5 Hz, 0.3H)], [3.71 – 3.55 (m, 1.3 H); 3.53 – 3.39 (m, 1.7H)], 2.84 (td, J = 15.6, 15.0, 5.2 
Hz, 1H), 2.77-2.67 (m, 1H), 2.30 (dd, J = 9.4, 4.8 Hz, 1H), 2.19 (tq, J = 7.5, 2.7 Hz, 2H), 2.15 – 
2.05 (m, 1H), 1.75 (d, J = 2.4 Hz, 4H), 1.62 – 1.46 (m, 2H).  
13C NMR (126 MHz, CDCl3) δ [167.45; 167.29], [140.44; 140.11], [129.07; 129.05], [128.10; 
128.01], [127.51, 127.35], [78.87; 78.65], [76.26; 76.24], [63.00; 62.33], [58.18; 56.81], [52.96; 
51.52], [38.34; 38.24], [32.80; 30.82], [26.40; 26.33, [18.52; 18.48], 3.57. 
FT-IR (cm-1): 3406, 2919, 2863, 1717, 1195 
HRMS (ESI) m/z [M+H] calcd for C17H22NO2, 272.1651; found: 272.1642 





To a solution of 3.63 (247.7mg, 0.75 mmol) in 5.5 mL tetrahydrofuran at -78°C under argon 
atmosphere was added dropwise a solution of lithium bis(trimethylsilyl)amide (1M in 
tetrahydrofuran, 0.83 mL, 0.83 mmol).  The reaction was stirred for 1 hour at -78°C and then a 













was added dropwise at -78°C.  The reaction was stirred at -78°C for 1h and then warmed to 0°C 
for 4h.  The reaction was quenched with 10 mL of a saturated aqueous solution of ammonium 
chloride.  The mixture was extracted with EtOAc (3x20 mL) and the combined organic layers 
were dried over MgSO4, filtered and concentrated in vacuo.  The resulting residue was purified by 
flash column chromatography on silica gel eluting from 2 to 10% EtOAc/Hex to afford 109.0 mg 
(35%) of 3.64 as a clear oil.  Rf= 0.5 (10% EtOAc/Hex) 
 
1H NMR (500 MHz, CDCl3) δ 3.76 (dd, J = 10.5, 4.2 Hz, 1H), 3.55 (dd, J = 10.4, 6.3 Hz, 1H), 3.26 
(ddd, J = 6.6, 4.2, 2.3 Hz, 1H), 2.88 (ddd, J = 8.9, 5.8, 2.3 Hz, 1H), 2.15 (ddt, J = 6.9, 4.6, 2.6 Hz, 
2H), 1.91 – 1.81 (m, 1H), 1.74 (t, J = 2.5 Hz, 3H), 1.73 – 1.52 (m, 3H), 0.94 (s, 9H), 0.88 (s, 9H), 
0.20 (d, J = 22.2 Hz, 6H), 0.05 (s, 6H). 
13C NMR (126 MHz, CDCl3) δ 175.94, 78.60, 76.09, 65.41, 57.38, 54.71, 28.31, 26.85 
FT-IR (cm-1): 2929, 2857, 1744, 1390 
HRMS (ESI) m/z [M+H] calcd for C22H44NO2Si2, 210.2911; found: 210.2912 
Optical Rotation: -20.82 (c=0.2, CHCl3, 22°C) 
 
2-(tert-Butyl) 1-methyl (1S)-2-azabicyclo[2.1.0]pentane-1,2-dicarboxylate 
 
To a solution of (+) 3.71 (6.16g, 20.0 mmol) in 200 mL tetrahydrofuran at 0°C under argon 
atmosphere was added dropwise a solution of lithium bis(trimethylsilyl)amide (1M in 
tetrahydrofuran, 30 mL, 30 mmol).  The reaction was stirred at 0°C for 1 hour and then 30 mL of a 
saturated aqueous solution of ammonium chloride was added slowly and the quenched reaction 











extracted with ethyl acetate (3x50 mL) and the combined organic layers were dried over MgSO4, 
filtered and concentrated in vacuo.  The resulting residue was purified by flash column 
chromatography on silica gel eluting with 20% EtOAc/Hex to obtain 3.1109g (68%) of 3.72 as a 
slightly yellow oil.  Rf=0.2 (20% EtOAc/Hex) 
 
1H NMR (500 MHz, CDCl3) δ 3.92 (dd, J = 8.7, 4.0 Hz, 1H), 3.72 (s, 3H), 3.31 – 3.25 (m, 1H), 
2.30 – 2.24 (m, 1H), 1.79 (t, J = 5.9 Hz, 1H), 1.39 (s, 9H), 1.31 (dd, J = 5.7, 3.0 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 169.80, 157.97, 80.62, 52.24, 51.18, 47.07, 28.24, 22.66, 19.08. 
FT-IR (cm-1): 2977, 2893, 1709, 1368 
HRMS (ESI) m/z [M+Na] calcd for C11H18NO4Na: 250.1055; found: 250.1055 
Optical Rotation: +180.0 (c=0.2, CHCl3, 22°C) 
2-(tert-Butyl) 1-methyl (1R)-2-azabicyclo[2.1.0]pentane-1,2-dicarboxylate 
 
To a solution of (-) 3.73 (1.90 g, 4.76 mmol) in 47.6 mL of tetrahydrofuran at 0°C under argon 
atmosphere was added dropwise a solution of lithium bis(trimethylsilyl)amide (1M in 
tetrahydrofuran, 7.13 mL, 7.13 mmol).  The reaction was stirred at 0°C for 1 hour. The reaction 
was quenched with 10 mL of a saturated aqueous solution of ammonium chloride and the mixture 
concentrated in vacuo to remove the tetrahydrofuran.  The resulting aqueous solution was 
extracted with ethyl acetate (3x20 mL) and the combined organic layers were dried over MgSO4, 
filtered and concentrated in vacuo.  The resulting residue was purified by flash column 
chromatography on silica gel eluting with 20% EtOAc/Hex to obtain 456.2 mg (42%) of (-) 3.72 as 














All spectral data matched (+) 3.72. 




To a solution of (+) 3.72 (2.2726g, 10.0 mmol) in 50 mL tetrahydrofuran at -78°C under argon 
atmosphere was added dropwise a solution of diisobutylaluminum hydride (1.2M in toluene, 16.7 
mL, 20.0 mmol) over 5 minutes.  After addition the reaction was warmed to 0°C and stirred for 30 
minutes.  50 mL of ethyl acetate followed by 50 mL of a saturated solution of potassium sodium 
tartrate were added dropwise and the mixture was warmed to 23°C and stirred for 2h.  The layers 
were separated and the aqueous layer was further extracted with ethyl acetate (3x50 mL).  The 
combined organic layers were dried over MgSO4, filtered and concentrated in vacuo. The 
resulting residue was purified by flash column chromatography on silica gel eluting with 1:1 
EtOAc/Hex to obtain 1.6526g (68%) of 3.74 as a white foam.  Rf=0.35 (2:1 EtOAc:Hex).   
 
1H NMR (500 MHz, CDCl3) δ 4.20 – 4.14 (m, 1H), 3.88 (dd, J = 8.4, 4.0 Hz, 1H), 3.55 (d, J = 12.5 
Hz, 1H), 3.28 (dd, J = 8.4, 0.9 Hz, 1H), 1.84 (dddd, J = 4.7, 3.9, 1.8, 0.9 Hz, 1H), 1.08 (dt, J = 5.8, 
1.5 Hz, 1H), 0.99 (t, J = 5.9 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 159.39, 80.75, 63.45, 52.02, 28.32, 19.93, 11.67. 
FT-IR (cm-1): 3418, 2977, 2889, 1701, 1365 
HRMS (ESI) m/z [M+Na] calcd for C10H17NO3Na: 222.1106; found: 222.1107  














To a solution of (+) 3.74 (150.0 mg, 0.75 mmol) in 2 mL tetrahydrofuran under argon atmosphere 
at 23°C was added portion-wise sodium hydride (60% dispersion in mineral oil, 33.0 mg, 0.83 
mmol).  The reaction was stirred for 1 hour at 23°C and then a solution of 1-bromobut-2-yne 
(199.5 mg, 1.13 mmol) in 1 mL of tetrahydrofuran was added dropwise over 1 minute.  The 
reaction was stirred for 22 hours at 23°C and then quenched with 5 mL of a saturated aqueous 
solution of ammonium chloride and extracted with ethyl acetate (2x10 mL).  The combined 
organic layers were washed with brine (1x10 mL), dried over MgSO4, filtered and concentrated in 
vacuo.  The resulting residue was purified by flash column chromatography on silica gel eluting 
with 3:1 Hex:EtOAc to obtain 113.0 mg (60%) of 3.75 as a colorless oil.  Rf=0.6 (2:1 Hex:EtOAc).   
 
1H NMR (500 MHz, CDCl3) δ 4.33 (d, J = 12.1 Hz, 1H), 4.29 – 4.15 (m, 2H), 3.89 (dd, J = 8.4, 3.9 
Hz, 1H), 3.47 (d, J = 12.1 Hz, 1H), 3.29 (d, J = 8.4 Hz, 1H), 1.84 (td, J = 2.4, 1.1 Hz, 4H), 1.44 (s, 
9H), 0.99 (dd, J = 5.7, 1.9 Hz, 1H), 0.89 (t, J = 5.8 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ 158.61, 82.70, 80.02, 77.36, 75.20, 68.84, 58.72, 50.51, 28.51, 
19.18, 10.98, 3.77.  
FT-IR (cm-1): 2977, 2890, 1697, 1364 
HRMS (ESI) m/z [M+Na] calcd for C14H21NO3Na: 274.1419; found: 274.1431 














A flame-dried microwave vial was charged with 3.54 (55.4 mg, 0.2 mmol) and [Rh(cod)2]BF4 (8.1 
mg, 0.02 mmol), sealed, and vacuum-purged/argon backfilled 3 times before 2 mL of 1,2-
dichloroethane was added and carbon monoxide was bubbled through the solution via a long 
needle attached to a balloon with an additional vent needle for 10 minutes.  The carbon monoxide 
source was removed and the sealed reaction stirred at 25°C.  After 1 hour the vial was opened 
and the carbon monoxide released into the hood.  The reaction was concentrated in vacuo and 
the residue purified by flash column chromatography on silica gel eluting with EtOAc to afford 
27.2 mg (83%) of 4.2 as a clear oil.  Rf=0.2 (100% EtOAc) 
 
1H NMR (500 MHz, CDCl3) δ 6.78 – 6.73 (m, 1H), 3.92 (p, J = 1.8 Hz, 2H), 2.41 – 2.34 (m, 2H), 
2.17 (ddd, J = 7.0, 4.6, 2.4 Hz, 2H), 1.74 (dd, J = 8.1, 6.9 Hz, 5H). 
13C NMR (126 MHz, CDCl3) δ 175.34, 139.35, 137.94, 78.73, 76.31, 46.76, 27.09, 24.82, 18.59, 
3.72. 
FT-IR (cm-1): 3249, 2920, 2857, 1718, 1683 

























To a solution of (+) 3.74 (300.0 mg, 1.5 mmol) in 6 mL tetrahydrofuran under argon atmosphere 
was added portion-wise sodium hydride (60% dispersion in mineral oil, 66.0 mg, 1.65 mmol).  The 
reaction was stirred at 23°C for 30 min and then allyl bromide (0.19 mL, 2.25 mmol) was added 
dropwise at 23°C.  The reaction was stirred for 2.5 h at 23°C and then quenched with 10 mL of a 
saturated aqueous solution of ammonium chloride and extracted with ethyl acetate (3x10 mL).  
The combined organic layers were washed with brine (1x15 mL), dried over MgSO4, filtered and 
concentrated in vacuo.  The resulting residue was purified by flash column chromatography on 
silica gel eluting with 3:1 Hex:EtOAc to obtain 319.3 mg (89%) of 4.11 as a slightly yellow oil.  
Rf=0.6 (2:1 Hex:EtOAc).   
 
1H NMR (500 MHz, CDCl3) δ 5.91 (ddt, J = 17.3, 10.7, 5.6 Hz, 1H), 5.27 (dq, J = 17.3, 1.7 Hz, 
1H), 5.17 (dt, J = 10.4, 1.5 Hz, 1H), 4.28 (d, J = 12.1 Hz, 1H), 4.14 – 4.02 (m, 2H), 3.90 (dd, J = 
8.4, 3.9 Hz, 1H), 3.39 (d, J = 12.1 Hz, 1H), 3.29 (d, J = 8.4 Hz, 1H), 1.84 – 1.78 (m, 1H), 1.44 (s, 
9H), 0.98 (dd, J = 5.7, 1.9 Hz, 1H), 0.90 – 0.84 (m, 1H). 
13C NMR (126 MHz, CDCl3) δ 158.59, 134.97, 117.14, 79.94, 72.10, 69.24, 50.84, 28.53, 19.09, 
10.86. 
FT-IR (cm-1): 2977, 2888, 1700, 1390 
HRMS (ESI) m/z [M+Na] calcd for C13H21NO3Na, 262.1219; found: 262.1438 
Optical Rotation: +30.57 (c=0.2, CHCl3, 22°C) 




















To a solution of 4.11 (143.6 mg, 0.6 mmol) in 6 mL toluene in a sealed microwave vial under 
argon atmosphere at 23°C was added a solution of [Rh(CO)2Cl]2 (23.3 mg, 0.06 mmol) in 6 mL 
toluene.  Carbon monoxide was bubbled through the solution via a balloon with vent needle for 
10min and then the balloon and vent needle were removed and the reaction was stirred at 23°C 
for 24h.  The carbon monoxide was vented into the hood and the reaction concentrated in vacuo.  
The resulting residue was purified by column chromatography on silica gel eluting with 5% 
EtOAc/Hex to obtain 40.9 mg of 4.12 (29%) and 41.0 mg of 4.13 (29%) both as slightly yellow 
oils.   
 
tert-Butyl (E)-allyl(2-(allyloxy)vinyl)carbamate (4.12) 
1H NMR (500 MHz, CDCl3) δ 6.46 (dt, J = 17.0, 10.6 Hz, 1H), 5.99 (s, 1H), 5.95 – 5.85 (m, 1H), 
5.76 (d, J = 11.0 Hz, 1H), 5.32 – 5.14 (m, 3H), 5.11 (dd, J = 10.3, 1.9 Hz, 1H), 4.19 (s, 2H), 3.98 
(dt, J = 5.7, 1.5 Hz, 2H), 1.46 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 152.96, 134.67, 132.28, 130.77, 118.95, 117.65, 117.30, 80.53, 
71.19, 70.89, 28.37. 
FT-IR (cm-1):  2956, 2924, 1459, 1378 
HRMS (ESI) m/z [M+H] calcd for C13H22NO3, 262.1419; found: 262.1409 
 
tert-Butyl (E)-(1-(allyloxy)prop-1-en-2-yl)(vinyl)carbamate (4.13) 
1H NMR (500 MHz, CDCl3) δ 6.87 (d, J = 11.4 Hz, 1H), 6.52 – 6.40 (m, 2H), 5.93 – 5.85 (m, 1H), 
5.31 – 5.25 (m, 1H), 5.25 – 5.14 (m, 2H), 4.97 (dd, J = 10.1, 2.0 Hz, 1H), 4.19 (d, J = 1.1 Hz, 2H), 
3.97 (dt, J = 5.8, 1.4 Hz, 2H), 1.47 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 152.87, 134.09, 131.78, 131.11, 118.20, 115.73, 114.06, 80.44, 
70.98, 65.35, 28.43. 








To a solution of 3.74 (224.0 mg, 1.12 mmol) in 4.5 mL tetrahydrofuran at 23°C under argon 
atmosphere was added portion-wise sodium hydride (60% dispersion in mineral oil, 49.3 mg, 1.23 
mmol).  The reaction was stirred at 23°C for 30min and then methyl iodide was added (0.1 mL, 
1.68 mmol).  The reaction was stirred for 1h at 23°C and then quenched by the addition of 5 mL 
of a saturated aqueous solution of ammonium chloride.  The mixture was extracted with ethyl 
acetate (3x15 mL) and the combined organic layers were washed with brine (1x20 mL), dried 
over MgSO4, filtered and concentrated in vacuo.  The resulting residue was purified by flash 
column chromatography on silica gel eluting with 3:1 Hex:EtOAc to afford 230.0 mg (96%) of 4.24 
as a colorless oil.  Rf=0.5 (1:1 Hex:EtOAc) 
 
1H NMR (500 MHz, CDCl3) δ 4.23 (s, 1H), 3.89 (dd, J = 8.7, 4.0 Hz, 1H), 3.42 (d, J = 2.0 Hz, 3H), 
3.29 (d, J = 11.7 Hz, 2H), 1.81 (td, J = 4.2, 2.0 Hz, 1H), 1.43 (s, 9H), 0.97 (dt, J = 5.2, 2.1 Hz, 
1H), 0.85 (s, 1H). 
13C NMR (101 MHz, CDCl3) δ 158.59, 79.94, 77.36, 71.86, 58.98, 50.64, 28.46, 19.02, 10.85. 
FT-IR (cm-1): 2977, 2888, 1702, 1364, 1157 
HRMS (ESI) m/z [M+Na] calcd for C11H19NO3Na, 236.1263; found: 236.1262 














tert-Butyl (E)-allyl(2-methoxyvinyl)carbamate and tert-butyl (3-methoxyprop-1-en-2-
yl)(vinyl)carbamate 
 
To a solution of 4.24 (42.7 mg, 0.2 mmol) in 0.2 mL toluene under argon atmosphere was added 
[Rh(CO)2Cl]2 (3.9 mg, 0.01 mmol).  The reaction was stirred at 23°C for 18h and then 
concentrated in vacuo.  The resulting residue was purified by flash column chromatography on 
silica gel eluting with 5 to 10% EtOAc/Hex to afford 21.7 mg (51%) of 4.25 and 9.3 mg (22%) of 
4.26 both as slightly yellow oils.   
 
tert-Butyl (E)-allyl(2-methoxyvinyl)carbamate  
4.25 
1H NMR (500 MHz, CDCl3) δ 6.47 (dt, J = 16.9, 10.6 Hz, 1H), 5.98 (s, 1H), 5.75 (d, J = 11.0 Hz, 
1H), 5.27 – 5.19 (m, 1H), 5.12 (dd, J = 10.3, 1.7 Hz, 1H), 4.14 (s, 2H), 3.34 (s, 3H), 1.47 (s, 9H). 
FT-IR (cm-1): 2930, 2254, 1514, 1322 




1H NMR (500 MHz, CDCl3) δ 6.88 (d, J = 11.4 Hz, 1H), 6.52 – 6.40 (m, 2H), 5.24 – 5.15 (m, 1H), 
4.98 (dd, J = 10.1, 1.9 Hz, 1H), 4.14 (d, J = 1.0 Hz, 2H), 3.34 (s, 3H), 1.48 (s, 9H). 
FT-IR (cm-1): 2955, 2923, 1650, 1158 




















To a solution of 3.72 (45.5 mg, 0.2 mmol) in 0.2 mL toluene under argon atmosphere was added 
[Rh(CO)2Cl]2 (3.9 mg, 0.01 mmol).  The reaction was heated to 80°C for 24h, cooled to 25°C and 
then concentrated in vacuo.  The resulting residue was purified by flash column chromatography 
on silica gel  eluting with  to afford 15.8 mg (35%) of 4.27 and 4.28 as a 6:1 mixture, 3.6 mg (8%) 
4.29 and 4.7 mg (10%) of 4.30 all as colorless oils.   
 




1H NMR (500 MHz, CDCl3) δ 6.93 (d, J = 11.2 Hz, 1H), 6.58 (ddd, J = 17.0, 11.2, 10.1 Hz, 1H), 
6.17 (s, 1H), 5.57 (ddd, J = 17.0, 1.7, 0.8 Hz, 1H), 5.46 (dt, J = 10.0, 1.0 Hz, 1H), 3.81 (d, J = 0.7 
Hz, 3H), 1.48 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 166.84, 146.87, 130.89, 128.22, 117.75, 108.07, 85.36, 51.70, 
27.43. 
FT-IR (cm-1): 2984, 1739, 1235, 1045 
































To a solution of (+)-3.74 (597.8 mg, 3 mmol) in 12 mL tetrahydrofuran at 0°C under argon 
atmosphere was added NaH (144 mg, 60% dispersion in mineral oil, 3.6 mmol).  The reaction 
was stirred for 30 minutes at 0°C and then propargyl bromide (80% wt. in toluene, 0.5 mL, 4.5 
mmol) was added dropwise over 1 minute at 0°C.  The reaction was allowed to warm to 23°C and 
stirred for 15 hours.  The reaction was quenched by the addition of 10 mL of a saturated aqueous 
solution of ammonium chloride and the resulting mixture was concentrated in vacuo to remove 
the tetrahydrofuran.  The resulting solution was extracted with ethyl acetate (3x30 mL), dried over 
MgSO4 and concentrated in vacuo.  The resulting residue was purified by column 
chromatography on silica gel eluting with 2:1 Hex:EtOAc to afford 634.4 mg (89%) of (+)-5.18 as 
a yellow oil.  Rf= 0.30 (1:1 EtOAc/Hex) 
 
1H NMR (500 MHz, CDCl3) δ 4.39 – 4.21 (m, 3H), 3.89 (dd, J = 8.5, 3.9 Hz, 1H), 3.50 (d, J = 12.4 
Hz, 1H), 3.29 (d, J = 8.5 Hz, 1H), 2.42 (t, J = 2.4 Hz, 1H), 1.85 (t, J = 4.0 Hz, 1H), 1.44 (s, 9H), 
1.01 (dd, J = 5.7, 2.0 Hz, 1H), 0.89 (s, 1H). 
13C NMR (126 MHz, CDCl3) δ 158.51, 80.03, 79.76, 74.65, 68.96, 67.18, 58.03, 50.30, 28.47, 
19.19, 10.98. 
FT-IR (cm-1): 2976.2, 2889.3, 1697.6, 1456.6 
HRMS (ESI) m/z [M+Na] calcd for C13H19NO3Na, 260.1263; found: 260.1248 















(-)-5.18 was prepared from (-)-3.74 following the above procedure (79%).  All spectral data 
matched above.   




To diisopropylamine (0.35 mL, 2.0 mmol) in 4 mL tetrahydrofuran at -78°C under argon 
atmosphere was added dropwise a solution of n-BuLi (2.31 M in hexanes, 1.0 mL, 2.3 mmol) and 
the mixture was stirred for 15 minutes at -78°C.  A solution of (+)-5.18 (400.0 mg, 1.7 mmol) in 2 
mL tetrahydrofuran was added dropwise over 2 minutes at -78°C and then the flask was rinsed 
with 0.5 mL tetrahydrofuran.  The mixture was stirred at -78°C for 1 hour and then methyl 
chloroformate (0.16 mL, 2.0 mmol) was added dropwise at -78°C.  The reaction was allowed to 
warm to 25°C over 1 hour and stirred for 2 hours at 0°C.  The reaction was quenched with 5 mL 
of methanol and 5 mL of a saturated solution of aqueous ammonium chloride. The resulting 
mixture was extracted with ethyl acetate (3x15 mL) and the combined organic layers were dried 
over MgSO4, filtered and concentrated in vacuo.  The resulting residue was purified by flash 
column chromatography on silica gel eluting with 4:1 Hex:EtOAc to afford 469.1 mg (94%) of (+)-
5.19 as a colorless oil.  Rf= 0.2 (30% EtOAc/Hex) 
 
1H NMR (400 MHz, CDCl3) δ 4.48 – 4.30 (m, 3H), 3.88 (dd, J = 8.5, 3.9 Hz, 1H), 3.77 (s, 3H), 
3.50 (d, J = 12.2 Hz, 1H), 3.29 (d, J = 8.4 Hz, 1H), 1.84 (dd, J = 7.1, 3.0 Hz, 1H), 1.43 (s, 9H), 














13C NMR (101 MHz, CDCl3) δ 158.52, 153.63, 83.75, 80.20, 77.99, 77.36, 69.68, 57.84, 52.90, 
50.19, 28.46, 19.32, 11.11. 
FT-IR (cm-1):2975.98, 2237.3, 1698.7, 1351.7 
HRMS (ESI) m/z [M+Na] calcd for C15H21NO5Na, 318.1317; found: 318.1308 





To diisopropylamine (0.17 mL, 1.1 mmol) in 3 mL tetrahydrofuran at -78°C under argon 
atmosphere was added dropwise a solution of n-BuLi (2.5 M in hexanes, 0.44 mL, 1.1 mmol) and 
the mixture stirred for 15 minutes at -78°C.  A solution of (+)-5.18 (237.8 mg, 1.0 mmol) in 2 mL 
tetrahydrofuran was added dropwise over 2 minutes at -78°C.  The mixture was stirred at -78°C 
for 30 minutes and then benzyl chloroformate (3.0 M in toluene, 0.40 mL, 1.2 mmol) was added 
dropwise. The reaction was stirred at -78°C for 15 minutes and then warmed to 0°C for 1 hour 
and then warmed to 23°C for an additional hour. The reaction mixture  was quenched with 5 mL 
of methanol and 5 mL of a saturated solution of aqueous ammonium chloride.  The mixture was 
extracted with ethyl acetate (3x15 mL) and the combined organic layers were dried over MgSO4, 
filtered and concentrated in vacuo.  The resulting residue was purified by flash column 
chromatography on silica gel eluting with 10% EtOAc/Hex to afford 141.9 mg (38%) of (+)-5.25 as 















1H NMR (500 MHz, CDCl3) δ 7.40 – 7.33 (m, 5H), 5.20 (s, 2H), 4.48 – 4.31 (m, 3H), 3.88 (d, J = 
4.9 Hz, 1H), 3.49 (s, 1H), 3.29 (d, J = 8.5 Hz, 1H), 1.90 – 1.82 (m, 1H), 1.43 (s, 9H), 1.02 (dd, J = 
6.0, 1.9 Hz, 1H), 0.89 (d, J = 7.0 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 158.51, 153.01, 134.78, 128.76, 128.75, 128.67, 83.98, 80.23, 
78.05, 69.67, 67.83, 66.81, 57.86, 50.18, 28.44, 19.31, 11.10. 
FT-IR (cm-1): 2976.0, 2889.9, 2235.7, 1705.2, 1238.5 
HRMS (ESI) m/z [M+Na] calcd for C21H25NO5Na, 394.1630; found: 394.1639 
Optical Rotation:  +21.54 (c=0.2, CHCl3, 22°C) 
(-)-5.25 was prepared from (-)-5.18 following the above procedure (42%).  All spectral data 
matched above. 
Optical Rotation: -18.41 (c=0.2 CHCl3, 22°C) 
Method for ee determination: Agilent 1260 Infinity SFC, IA-3 column, 2.5% MeOH/CO2, 2.5 
mL/min, 6.98 min, 7.59 min. 
 
General Procedure for the synthesis of Spirocycles: 
A 10 mL 2-neck round-bottomed flask with reflux condenser and rubber septum was flame-dried 
and cooled under argon.  The flask was charged with 0.2 mmol substrate and 0.004 mmol 
Pd2(dba)3 and then vacuum purge/argon back-filled three times. 1.5 mL 1,4-dioxane was added 
followed by 0.016 mmol tris(1,1,1,3,3,3-hexafluoropropan-2-yl) phosphite as a stock solution in 
0.5 mL 1,4-dioxane. The flask was lowered into an oil bath preheated to 60°C and stirred until 
substrate was consumed as judged by TLC analysis (Hex/EtOAc).  Upon consumption of 
substrate, reaction was cooled to 25°C, concentrated and loaded onto SiO2 for purification by 








87% colorless oil; 65:35 mixture of rotamers; purified 10 to 20% EtOAc/Hex; Rf=0.6 (3:2 
EtOAc:Hex) 
 
1H NMR (400 MHz, CDCl3) δ 5.92 – 5.72 (m, 2H), 5.64 (dt, J = 19.1, 2.6 Hz, 1H), 5.02 (m, 1H), 
4.87 (dd, J=17.1, 2.7 Hz, 0.4H) 4.77 (dd, J = 17.3, 2.8 Hz, 0.6H), 4.44 – 4.33 (m, 1H), 4.32-4.27 
(dt, J=15.6, 2.1 Hz, 0.35H), 4.22-4.17 (m, 1.65H), 3.83-3.72 (m, 1H), [3.70 (s). 3.68 (s), 3H], [1.42 
(s), 1.39 (s), 9H]. 
13C NMR (101 MHz, CDCl3) δ [166.78; 166.70], [165.61; 164.95], [152.82; 152.46], [132.81; 
132.74], [124.24; 124.09], [111.26; 111.03], [81.19; 80.37], [76.96; 76.52], [73.83; 72.46], [71.99; 
71.92], [54.69; 54.64], [51.63; 51.55], [28.62; 28.59]. 
FT-IR (cm-1): 2986.4, 1695.4, 1384.8, 1209.6 
HRMS (ESI) m/z [M+Na] calcd for C15H21NO5Na, 318.1317; found: 318.1311 















83% colorless oil; 65:35 mixture of rotamers; purified 10% EtOAc/Hex, Rf=0.4 (30% EtOAc:Hex) 
98.6% ee 
 
1H NMR (500 MHz, CDCl3) δ 7.40 – 7.28 (m, 5H), 5.91 – 5.73 (m, 2H), 5.69 (dt, J = 22.0, 2.6 Hz, 
1H), 5.17 (d, J = 3.2 Hz, 1H), 5.14 (s, 1H), 5.04 (ddd, J = 17.3, 9.7, 2.3 Hz, 1H), 4.89 (dd, J = 
17.2, 2.7 Hz, 0.35H), 4.78 (dd, J = 17.2, 2.8 Hz, 0.65H), 4.41 – 4.35 (m, 1H), 4.33 – 4.24 (m, 
0.35H), 4.23 – 4.12 (m, 1.65H), 3.79 (d, J = 8.4 Hz, 0.65H), 3.74 (d, J=8.3 Hz, 0.35H), [1.44 (s), 
1.38 (s), 9H]. 
13C NMR (126 MHz, CDCl3) δ [166.07; 165.99], 165.45, [152.82; 152.49], 136.01, [132.81; 
132.67], 128.72, [128.44; 128.35], 128.39, [124.27; 124.16], [111.44; 111.12] [81.20; 80.41], 
[77.05; 76.59], [73.87; 72.47], [72.05; 71.99], [66.40; 66.34], 54.65, 28.61. 
FT-IR (cm-1): 2973, 1699, 1386, 1193 
HRMS (ESI) m/z [M+Na] calcd for C21H25NO5Na, 394.1630; found: 394.1633 
Optical Rotation: +104.59 (c=0.2, CHCl3, 22°C) 
Method for ee determination: Agilent 1260 Infinity SFC, IA-3 column, 2.5% MeOH/CO2, 2.5 




To a solution of (+)-5.18 (237.8 mg, 1 mmol) in 10 mL CH2Cl2 at 0°C under argon atmosphere 
was added trifluoroacetic acid (0.38 mL, 5 mmol).  The reaction was allowed to warm to 23°C 













added.  The layers were separated and the aqueous layer was further extracted with CH2Cl2 
(3x10 mL).  The combined organic layers were washed with 10 mL brine, dried over MgSO4, 
filtered and concentrated in vacuo to obtain 102.9 mg of an orange oil which was used in the next 
step without further purification.   
 
To the above compound and freshly distilled benzaldehyde (0.23 mL, 2.25 mmol) in 3 mL 1,2-
dichloroethane under argon atmosphere at 23°C was added sodium triacetoxyborohydride (476.8 
mg, 2.25 mmol) in one portion.  The reaction was stirred at 23°C for 16 hours and then 10 mL of 
a saturated aqueous solution of NaHCO3 was added.  The mixture was extracted with CH2Cl2 
(3x10 mL) and the combined organic layers were washed with 10 mL brine, dried over MgSO4, 
filtered and concentrated in vacuo.  The resulting residue was purified by column chromatography 
on silica gel eluting with 2:1 Hex:EtOAc to afford 116.3 mg (51%, 2 steps) of (+)-5.29 as a yellow 
oil. 
 
1H NMR (500 MHz, CDCl3) δ 7.37 – 7.23 (m, 5H), 4.19 (dd, J = 15.9, 2.4 Hz, 1H), 4.12 (dd, J = 
15.9, 2.4 Hz, 1H), 3.70 (d, J = 12.9 Hz, 1H), 3.64 – 3.56 (m, 2H), 3.51 (d, J = 11.5 Hz, 1H), 3.44 
(d, J = 12.9 Hz, 1H), 2.43 – 2.34 (m, 2H), 1.78 (t, J = 4.4 Hz, 1H), 1.37 (dd, J = 5.5, 1.7 Hz, 1H), 
0.63 (t, J = 5.7 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 138.84, 128.93, 128.33, 127.03, 79.96, 74.44, 71.78, 57.96, 56.06, 
54.46, 50.11, 14.09, 11.91. 
FT-IR (cm-1): 3289, 2856, 1734, 1241 
HRMS (EI) m/z [M] calcd for C15H17NO, 227.1310; found: 227.1311 








To a solution of (+)-3.74 (99.6 mg, 0.5 mmol) in 2 mL tetrahydrofuran at 0°C under argon 
atmosphere was added sodium hydride (24.0 mg, 60% dispersion in mineral oil, 0.6 mmol).  The 
reaction was stirred 30 minutes to 0°C and then 3-bromo-1-phenylpropyne (146.3 mg, 0.75 
mmol) was added dropwise.  The reaction was allowed to warm to 23°C and stirred for 16 hours.  
The reaction was quenched by the addition of 5 mL of a saturated aqueous solution of 
ammonium chloride and then was extracted with ethyl acetate (3x15 mL), and the combined 
organic layers were dried over MgSO4 and concentrated in vacuo.  The resulting residue was 
purified by column chromatography on silica gel eluting with 4:1 Hex:EtOAc to afford 120.4 mg 
(77%) of (+)-5.31 as a slightly yellow oil.  Rf= 0.65 (3:2 EtOAc/Hex) 
 
1H NMR (500 MHz, CDCl3) δ 7.47 – 7.40 (m, 2H), 7.31 (dd, J = 5.5, 1.9 Hz, 3H), 4.50 (q, J = 15.9 
Hz, 2H), 4.43 (d, J = 12.2 Hz, 1H), 3.92 (dd, J = 8.7, 3.9 Hz, 1H), 3.64 – 3.47 (m, 1H), 3.31 (d, J = 
8.4 Hz, 1H), 1.88 (t, J = 3.9 Hz, 1H), 1.44 (s, 9H), 1.02 (dd, J = 5.7, 1.9 Hz, 1H), 0.92 (s, 1H). 
13C NMR (101 MHz, CDCl3) δ 158.57, 131.85, 128.53, 128.36, 122.73, 86.45, 85.15, 80.02, 
77.36, 69.07, 58.86, 50.44, 28.47, 19.22, 11.04. 
FT-IR (cm-1): 2976, 2889, 1700, 1390,1365 
HRMS (ESI) m/z [M+Na] calcd for C19H23NO3Na, 336.1576; found: 336.1593 


















To a solution of (+)-3.74 (99.6 mg, 0.5 mmol), propiolic acid (52.5 mg, 0.75 mmol) and 4-
dimethylaminopyridine (3.1 mg, 0.025 mmol) in 2.5 mL CH2Cl2 at 0°C under argon atmosphere 
was added N,N-dicyclohexylcarbodiimide (154.7 mg, 0.75 mmol) in one portion.  After addition 
the reaction was warmed to 23°C over 30 minutes and stirred 17 hours.  The reaction was diluted 
with 50 mL CH2Cl2 and filtered through Celite. The resulting solution was washed with 30 mL 2 N 
HCl, 30 mL of a saturated solution of aqueous NaHCO3, and 30 mL brine, dried over MgSO4, 
filtered and concentrated in vacuo.  The resulting residue was purified by column chromatography 
on silica gel eluting with 9:1 Hex:EtOAc to afford 105.7 mg (84%) of (+)-5.32 as a yellow oil.  Rf= 
0.7 (1:1 EtOAc/Hex) 
 
1H NMR (500 MHz, CDCl3) δ 4.90 (d, J = 13.0 Hz, 1H), 4.21 (d, J = 13.1 Hz, 1H), 3.86 (dd, J = 
8.6, 4.0 Hz, 1H), 3.26 (d, J = 8.5 Hz, 1H), 2.94 (s, 1H), 1.86 (d, J = 3.6 Hz, 1H), 1.43 (s, 9H), 1.11 
(dd, J = 5.9, 2.1 Hz, 1H), 0.99 (d, J = 6.4 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 158.21, 152.77, 80.39, 77.36, 75.41, 74.65, 66.08, 49.12, 28.42, 
20.22, 11.72. 
FT-IR (cm-1): 2978, 2118, 1703, 1191 
HRMS (ESI) m/z [M+Na] calcd for C13H17NO4Na, 274.1055; found: 274.1074 


















To a solution of (+)-3.74 (99.6 mg, 0.5 mmol), 2-butynoic acid (63.1 mg, 0.75 mmol) and 4-
dimethylaminopyridine (3.1 mg, 0.025 mmol) in 2.5 mL CH2Cl2 at 0°C under argon atmosphere 
was added N,N-dicyclohexylcarbodiimide (154.7 mg, 0.75 mmol) in one portion.  After addition 
the reaction was warmed to 23°C over 30 minutes and stirred 17 hours.  The reaction was diluted 
with 50 mL CH2Cl2 and filtered through Celite. The resulting solution was washed with 30 mL 2 N 
HCl, 30 mL of a saturated solution of aqueous NaHCO3, and 30 mL brine, dried over MgSO4, 
filtered and concentrated in vacuo.  The resulting residue was purified by column chromatography 
on silica gel eluting with 9:1 Hex:EtOAc to afford 107.3 mg (81%) of (+)-5.33 as a yellow oil.  Rf= 
0.8 (1:1 EtOAc/Hex) 
 
1H NMR (500 MHz, CDCl3) δ 4.86 (d, J = 13.0 Hz, 1H), 4.17 (d, J = 11.5 Hz, 1H), 3.86 (dd, J = 
8.7, 4.0 Hz, 1H), 3.26 (d, J = 8.4 Hz, 1H), 1.98 (s, 3H), 1.86 – 1.82 (m, 1H), 1.42 (s, 9H), 1.08 (dd, 
J = 5.9, 2.1 Hz, 1H), 0.98 (s, 1H). 
13C NMR (126 MHz, CDCl3) δ 158.24, 153.77, 86.26, 80.29, 77.36, 72.40, 65.46, 49.34, 28.42, 
20.13, 11.59, 3.95. 
FT-IR (cm-1): 2977, 2242, 1699, 1364 
HRMS (ESI) m/z [M+Na] calcd for C14H19NO4Na, 288.1212; found: 288.1218 



















To a solution of (+)-3.74 (199.3 mg, 1 mmol), N-tosylpropargylamine (261.6 mg, 1.25 mmol), 
triphenylphospine (367.2 mg, 1.4 mmol) in 4 mL toluene at 0°C under argon atmosphere was 
added dropwise diethylazodicarboxylate (40% wt solution in toluene, 0.22 mL, 1.4 mmol).  The 
reaction was stirred for 1 hour at 0°C and then warmed to 23°C over 30 minutes and stirred for 24 
hours.  The reaction was concentrated and filtered through a plug of silica gel washing with 100 
mL of 4:1 Hex:EtOAc and concentrated.  The resulting residue was purified by column 
chromatography on silica gel eluting with 9:1 Hex:EtOAc to afford 250.0 mg of (+)-5.34 along with 
N-tosylpropargylamine.  A second purification by column chromatography on silica gel eluting 
with 2:98 EtOAc:CH2Cl2 afforded 76.0 mg (20%) of pure (+)-5.34 as a clear oil.  Rf= 0.8 (3:2 
Hex:EtOAc) 
 
1H NMR (500 MHz, CCDl3) δ 7.72 (d, J = 8.3 Hz, 2H), 7.27 (d, J = 8.0 Hz, 2H), 4.38 – 4.25 (m, 
2H), 4.15 (d, J = 15.5 Hz, 1H), 3.84 – 3.78 (m, 1H), 3.27 (d, J = 8.5 Hz, 1H), 3.18 (s, 1H), 2.41 (s, 
3H), 2.01 (t, J = 2.4 Hz, 1H), 1.84 (s, 1H), 1.44 (s, 9H), 0.98 (dd, J = 5.8, 2.0 Hz, 1H), 0.89 (s, 
1H). 
13C NMR (126 MHz, CDCl3) δ 158.54, 143.58, 136.45, 129.54, 127.75, 80.43, 77.36, 77.26, 
73.73, 50.14, 46.93, 37.62, 28.36, 21.62, 19.55, 11.60. 
FT-IR (cm-1): 2977, 1703, 1349, 1156 
HRMS (ESI) m/z [M+Na] calcd for C20H26N2O4SNa, 413.1511; found: 413.1527 


















To diisopropylamine (0.073 mL, 0.52 mmol) in 1.2 mL tetrahydrofuran at -78°C under argon 
atmosphere was added dropwise a solution of n-BuLi (2.5 M in hexanes, 0.2 mL, 0.5 mmol) and 
the mixture stirred for 5 minutes at -78°C.  A solution of (+)-5.34 (169.0 mg, 0.43 mmol) in 1 mL 
tetrahydrofuran was added dropwise at -78°C.  The mixture was stirred at -78°C for 30 minutes 
and then methylchloroformate (0.04 mL, 0.52 mmol) was added dropwise over 1 minute at -78°C.  
The reaction was stirred at -78°C for 15 minutes and then warmed to 0°C and stirred for 1 hour.  
The reaction was quenched with 5 mL of a saturated solution of aqueous ammonium chloride and 
extracted with ethyl acetate (3x15 mL).  The combined organic layers were dried over MgSO4, 
filtered and concentrated in vacuo.  The resulting residue was purified by flash column 
chromatography on silica gel eluting with 10 to 20% Hex:EtOAc to afford 78.6 mg (41%) of (+)-
5.35 as a yellow oil.  Rf= 0.2 (30% EtOAc/Hex) 
 
1H NMR (600 MHz, CDCl3) δ 7.71 (d, J = 8.3 Hz, 2H), 7.29 (d, J = 8.1 Hz, 2H), 4.47 – 4.39 (m, 
2H), 4.09 (d, J = 15.7 Hz, 1H), 3.84 – 3.78 (m, 1H), 3.68 (s, 3H), 3.27 (s, 1H), 3.26 (s, 1H), 2.40 
(s, 3H), 1.83 (t, J = 3.8 Hz, 1H), 1.43 (s, 9H), 1.00 (dd, J = 5.8, 2.0 Hz, 1H), 0.91 (s, 1H). 
13C NMR (151 MHz, CDCl3) δ 158.56, 153.09, 144.03, 135.99, 129.82, 127.68, 81.42, 80.63, 
52.76, 51.56, 50.24, 47.69, 37.75, 28.38, 21.64, 19.80, 11.72. 
FT-IR (cm-1): 2977, 2240, 1713, 1435, 1351 
HRMS (ESI) m/z [M+Na] calcd for C22H28N2O6SNa, 471.1566; found: 471.1570 
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